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 The carotid bodies are small sensory organs located along the bifurcation of the 
carotid arteries.  They detect changes in blood gases and relay this information to the brain 
to allow for initiation of appropriate respiratory and cardiovascular responses.  A decrease 
in oxygen (hypoxia) sensed by the carotid body results in an increase in firing of the carotid 
sinus nerve and ultimately a change in one’s breathing pattern. An inability to respond to 
an acute hypoxic (low oxygen) episode via increased ventilation may result in death or lead 
to pathological or chronic conditions such as stroke and hypertension (Prabhakar et.al., 
2005).  The carotid bodies are therefore responsible for initiating the acute hypoxic 
ventilatory response (HVR) and blunting or attenuation of the HVR has been implicated in 
sudden infant death syndrome (SIDS) in ‘at risk’ infant groups (Calder et al., 1994; Horne 
et al., 2005; Gauda et. al., 2007).  
The exact mechanism(s) responsible for hypoxic chemotransduction by the carotid 
body remains controversial and are the subject of intense investigation. There is evidence 
indicating the energy-sensing enzyme AMP-activated protein kinase (AMPK) may play a 
critical role in the transduction of an acute hypoxic stimulus by the carotid bodies (Evans et. 
al., 2005; Wyatt et.al., 2007). Global AMPK α1 and AMPK α2 subunit knockout mice were 
used to gain further insight into the role AMPK has in acute oxygen-sensing in whole animal 
and in isolated oxygen-sensing cells of mice carotid bodies.  A two-chamber 
 iv 
plethysmography system was used to measure baseline breathing during normoxia (21% O2) 
and the hypoxic ventilatory response to 8% oxygen.  AMPK α1 subunit knockout mice had a 
significant attenuation in percent change in breathing frequency during hypoxic exposure and 
AMPK α2 knockouts also showed a significant decrease in percent change in minute 
ventilation.  The plethysmography data shows AMPKα subunits may be involved in baseline 
breathing and generation of acute hypoxic ventilatory responses.  Isolated type I cells from 
global knockout mice were also used in calcium imaging experiments.  Hypoxia induced 
Ca2+ signaling was inhibited by 85% in cells from AMPK α2 knockout mice whereas AMPK 
α1 KO mice showed a mixed response to hypoxia.  The cellular data seem to show that a 
decrease in response to hypoxia may be due to an effect at the level of the carotid body.  
These findings provide further support for the hypothesis that AMPK regulates acute hypoxic 
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Carotid bodies (CB) are small-paired sensory organs, which can be found along the 
bifurcation of the carotid arteries (Figure 1).  In 1926 Fernando De Castro discovered 
that the cell bodies of the carotid sinus nerve (CSN) lay within the petrosal sensory 
ganglion suggesting that the carotid body had sensory capabilities (De Castro, 1926).  In 
1928, De Castro went on to determine that the carotid body was indeed a sensory organ 
and not a gland, which he hypothesized was capable of detecting changes in the 
composition of blood (De Castro, 1928). From 1930-1933 Corneille Jean Francois 
Heymans, a Belgium physiologist, focused most of his time working on De Castro’s 
hypothesis of the CB being a chemoreceptor (De Castro, 2009). From these experiments, 
Heymans and collaborators were able to demonstrate that hyperventilation induced by a 
decrease in the partial pressure of oxygen in arterial blood (PaO2) and pH or an increase 
in partial pressure of carbon dioxide in arterial blood (PaCO2) was mediated via the 
carotid body (Heymans et.al.,1930). This work won Heymans the Nobel Prize in 
Physiology or Medicine in 1938 (De Castro, 2009).   
 It is now known that the carotid bodies are the primary peripheral arterial 
chemoreceptors (PAC) of mammals; they are responsible for sensing changes in the 
partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), and pH and 
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Figure 1. Anatomical location of the carotid bodies. 
The carotid bodies are small sensory organs located, bilaterally, at the bifurcation of the 
common carotid arteries and branch into the internal and external carotid arteries. The 
diagram indicates circulatory supply and the afferent nerve projections from the carotid 


































act to produce an increase in ventilatory response (Heymans et. al., 1930). Upon CSN 
resection, the hyperventilatory response ceased, thus illustrating the relationship between 
the CB and the hypoxia-mediated stimulation of the respiration rate (Heymans et. al., 
1930).   Carotid bodies are perfused with blood via one or more small arteries that 
originate near the branches of the carotid artery.  Blood drains into the internal jugular 
vein by one or two veins originating from a dense vascular plexus located on the surface 
of the organ.  Carotid bodies possess the highest blood flow relative to its size(1.5 and 2.0 
liters100g-1 min-1) of any other organ in the body (Gonzalez et. al., 1994; Kumar & Bin-
Jaliah, 2007).  Blood flow to the carotid body is important in determining the PO2 of the 
carotid body tissue.  The carotid body is highly vascularized, thus it is able to quickly 
(within seconds) (Kumar, 2009) sense changes in arterial blood partial pressure of 
oxygen (PO2), partial pressure of carbon dioxide (PCO2) and pH.  The ability of the 
carotid body to rapidly sense blood gas changes allows it to initiate appropriate 
physiological responses to the changes in an expedient manner (Barnett et. al., 1988).  
Carotid bodies sensory afferent innervations are from the carotid sinus nerve. Fibers from 
the afferent innervation ultimately project to the nucleus tractus solitarius, (NTS) of the 
medulla (Finley & Katz, 1992) and allow for initiation of respiratory and cardiovascular 
reflexes to ensure proper oxygenation to vital organs (Lahiri et. al., 2006).  Two main cell 
types comprise the carotid body, glomus cells and sustentacular cells, which form clusters 
surrounded by a dense net of fenestrated capillaries (Gonzalez et. al., 1992).  Glomus 
cells, also known as type I cells, are excitatory and originate from the neural crest, 
whereas sustentacular cells (type II cells) are similar to glial cells. Current research 
suggests type II cells in adult CB’s are functional and may be dormant stem cells which 
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proliferate in response to hypoxia and differentiate into new glomus cells (Pardal et.al., 
2007).  By contrast, glomus cells are more complex, expressing a number of voltage- and 
ligand-gated ion channels in addition to transient receptor potential channels and 
background K+ channels. Combinations of voltage-gated Na+, Ca2+, and K+ channels are 
expressed and the level of expression varies among mammalian species. For example, 
rabbit glomus cells have relatively large voltage gated inward Na+ currents, as well as 
sustained Ca2+ currents (ICa) (Lopez-Barneo et. al., 1988; Ureña et. al., 1989; Duchen & 
Biscoe, 1992), whereas, in rat type I cells, the Na+ current is either absent completely 
(Peers & Green, 1991; Fieber & McCleskey, 1993) or is present only at low densities 
(Stea & Nurse, 1991). Due to the presence of voltage-gated channels found within 
glomus cells, most are excitable and able to elicit action potentials (Ureña et. al., 1989) or 
calcium-dependent receptor potentials (Buckler & Vaughn-Jones, 1994). 
 Neurotransmitters (NT) found in the carotid body can be classified into two 
different categories, conventional and unconventional.  Conventional NT’s are located 
within synaptic vesicles and their actions are mediated through activation of membrane-
bound receptors often coupled to specific G-coupled proteins or ion channels.  
Transmitters found in this category include: acetylecholine (ACh), dopamine (DA), 
norepinephrine (NE), 5-hydroxytryptamine (5-HT), substance P (Sub. P), ATP and amino 
acids (Lahiri et. al., 2006).  Unconventional NT’s, which are not synaptically stored but 
instead are generated spontaneously through enzymatic reactions and express their 
biological actions via cytosolic enzymes or direct protein modifications.  Examples of 
unconventional NT’s would include nitric oxide (NO) and carbon monoxide (CO) 
(Gonzalez et. al., 1994; Lahiri et. al., 2006; Prabhakar, 2006; Lopez-Barneo et .al., 2008).  
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Release of neurotransmitters stimulates afferent nerve activity (i.e. ACh, Sub. P, 
Adenosine, and ATP) (Prabhakar et. al., 1989; Zhang et. al., 2000; Spyer et.al.,  2004) 
whereas some such as dopamine will inhibit nerve activity (Carroll et. al.,  2005; Prieto-
Lloret et. al., 2007).  Studies have shown that hypoxia induces release of both stimulatory 
and inhibitory NT’s during afferent nerve activation (Ureña et. al., 1989; Xu et. al., 




CO2 and Acid Sensing  
 
 The carotid body is excited by different “acidic stimuli,” such as: (A.) 
Hypercapnic Acidosis: rise in PCO2 with a concomitant decrease in extracellular pH; 
(B). Isohydric Hypercapnia: proportional increase in both PCO2 and extracellular 
[HCO3-] with maintained extracellular pH; and (C). Isocapnic Acidosis: decrease in 
extracellular pH and [HCO3-] at constant PCO2.  These “acidic stimuli” have been shown 
to elevate intracellular calcium, [Ca2+]i, in isolated rat type I cells resulting in decreased 
intracellular pH, (pHi), suggesting intracellular acidosis is responsible for inducing a rise 
in [Ca2+]i (Buckler & Vaughan-Jones, 1994a).  Decreases in pHi cause the cells to 
depolarize via K+ channel inhibition, resulting in voltage-gated Ca2+ influx.  Support for 
this model has been shown with evidence that acidosis inhibits whole-cell K+ currents in 
type I cells (Peers, 1990b; Stea et. al., 1991; Buckler & Vaughan-Jones, 1993).  
Additionally, Peers and Green (1991) indicated that an increase in pHi selectively inhibits 
Ca2+-activated K+ currents in CB type I cells of neonatal rats.  Past studies have 
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suggested that a fall in pHi may lead to Ca2+ entry through activation of the Na+-H+ 
exchanger, which would lead to a rise in intracellular Na+ ([Na+]i) and Ca2+ entry via a 
Na+-Ca2+ exchanger.  However, in the absence of extracellular Na+, [Na+]o, there was no 
significant effect on resting levels of [Ca2+]i.  In addition, when [Na+]o was removed and 
type I cells underwent depolarization/repolarization steps from -60mV to 0mV and back, 
recovery of [Ca2+]i was indeed slower in the absence of extracellular Na+.  However, the 
effect was quite small and therefore indicates that if Na+-Ca2+ exchanger is present it 
likely plays only a minor role in the homeostasis of [Ca2+]i.  Therefore, it seems as if the 
response of the carotid body to changes in pH and CO2 is not dependent upon specialized 
mechanisms for proton-extrusion, instead it is mediated through changes in the 
relationship between pHi and pHo of type I cells (Buckler et. al., 1991).   
 In addition to the relationship between pHi and pHo, it is believed that TASK 
channels, also known as, acid (or alkali) sensitive K+-channels of the tandem P-domain 
K+-channel family, take part in CO2-sensing within the type I cells of the CB.  These pH-
sensitive K+-channels are found in the brainstem neurons (Bayliss et. al., 2001; Duprat et. 
al., 1997) as well as the glomus cells of the carotid bodies (Buckler et. al., 2000). TASK 
channels belong to two main groups based upon structure and sequence homology, one 
group consists of TASK-1, TASK-3 and TASK-5 and the other TASK-2, 
TASK4/TALK2 and TALK 1 (Buckler et. al., 2007).  Out of all the TASK channels, the 
CB seems to have ones most similar to that of TASK-1 and TASK-3.  Buckler, et. al., 
(2000), has shown that in rat carotid body type I cells, brief pulses of isocapnic acidosis 
resulted in inhibition of the TASK-1 channels causing cell depolarization evoking a rapid 
increase in intracellular calcium levels.  Oxygen sensitivity of the current was also 
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decreased by the acidosis.  Further work done by Kim et. al., (2009) demonstrated that in 
rat carotid body type I cells, the predominant oxygen-sensitive TASK-like current is 
carried by a heteromultimer of TASK-1 and TASK-3.  These data lend further support to 
data published by Buckler et. al.,  (2007) wherein channel activity of the TASK-like K+ 
channels were inhibited by reducing pHo.  Data published from Trapp et. al., (2008) using 
TASK-1-/-, TASK-3-/-, and TASK-1/3 double knockout mice, showed that TASK-1 and 
not TASK-3 channels play a role in cell depolarization, calcium influx, and 




 Hypoxia stimulates neurotransmitter release from type I cells which leads to an 
increase in CSN firing rate and results in a change in ventilatory pattern until 
physiological PO2 levels are re-established and maintained.  Results from many studies 
suggest that hypoxic chemotransduction occurs through the inhibition of O2-sensitive K+ 
channels present in the type I cells (Lopez-Barneo et. al., 1988; Peers, 1990; Stea & 
Nurse, 1991; Buckler, 1997).  Potassium channel inhibition causes type I cells to 
depolarize allowing voltage-gated Ca2+ entry and NT release (Buckler & Vaughan-Jones, 
1994b; Ureña et. al., 1994).  The specific mechanism(s) by which K+ channels are 
inhibited via hypoxia in carotid body type I cells are still being examined and are the 
focus of this dissertation.  While the precise oxygen-sensing mechanism(s) still remain to 
be fully defined, two main hypotheses have been proposed: the Membrane and the 
Mitochondrial hypotheses.   
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Membrane Hypothesis 
 According to the membrane hypothesis, hypoxia suppresses K+ channels, 
resulting in depolarization of the membrane, Ca2+ influx, and cytosolic Ca2+ increase 
(Lopez-Barneo et. al., 1988; Buckler & Vaughan-Jones, 1994b).  If hypoxia is coupled to 
K+ channel inhibition through a membrane-delimited mechanism, this should be evident 
and maintained in an excised patch of membrane. Necessary elements required for the 
channels to be maintained should be found in the removed portion.  This has been 
demonstrated in certain experiments using adult rats (Riesco-Fagundo et. al., 2001), 
whereas in other experiments using neonatal rats, hypoxic inhibition was no longer 
maintained after excision (Wyatt & Peers, 1995).  If chemotransduction following a 
hypoxic exposure were truly a membrane-delimited process, then sensitivity to hypoxia 
should be maintained in the patch for a period of time following excision.  Elements 
necessary for O2-sensing need to be tightly adhered to the cell membrane otherwise they 
may be lost to the intracellular solution, resulting in attenuation of the cell’s oxygen-
sensing ability (William & Buckler, 2004).  Studies have illustrated ‘run down’ in 
activity of O2-sensitive K+ channel activity in rat type I cells when excised; however after 
ATP was added to the intracellular solution, channel activity recovered.  Recovery 
suggests that intracellular factors were necessary for O2-sensitive K+ channel activity and 
the potential for metabolic regulation (William & Buckler, 2004; Varas et. al., 2007).  In 
favor of the “membrane” hypothesis, Williams et. al., (2004) proposed that O2-sensing 
via the Ca2+-sensitive K+ (BKCa) channels in the rat CB is mediated via O2-sensitive 
dependent carbon monoxide production via heme oxygenase-2 (HO-2).  Heme 
oxygenase-2 is an enzyme, which in the presence of nicotinamide adenine dinucleotide 
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phosphate (NADPH) and molecular oxygen (O2), catalyzes the breakdown of celluar 
heme producing carbon monoxide (CO), iron, and biliverdin (BV) (Figure 2), which can 
be broken down further into bilirubin by BV reductase (Williams et. al., 2004). Evidence 
has emerged over the last 10-15 years suggesting that HO-2 may act as an O2 sensor 
through the production of CO, which is a BKCa channel activator (Lopez-Barneo et. al., 
2008).  It is believed that two K+ channels, Twik-related acid sensing K+ channels 
(TASK-like) and BKCa channels, may play a role in the hypoxic depolarization of type I 
cells of the rat (Buckler, 1997). Work done by Riesco-Fagundo et.al., (2001) and 
Williams et. al., (2004) have shown that under normoxic conditions HO-2 in the presence 
of CO, elicits an excitatory response on nearby BKCa channels assuring the channels 
remain open. While under hypoxia, no excitatory response is observed, likely because 
reduced CO levels combined with direct heme-dependent inhibition leads to K+ channel 
closure, further supporting the role of HO-2 to K+ channel activation.   
 As BKCa channels are regulated by CO and/or NADPH cofactors, it is believed 
that HO-2 functions as an acute O2-sensor in rat type I cells via regulation of BKCa 
channel activity through the changing balance between intracellular concentrations of 
HO-2 and the production of CO.  However, to date, no assessment has been made to 
outline the requirements necessary for hypoxic chemotransduction to occur within an 
intact rat carotid body (Williams et. al., 2004; Kemp, 2005; Lopez-Barneo et. al., 2008).  
The proposal of HO-2 acting as an O2 sensor has been challenged by experiments 
conducted in HO-2 knockout (KO) mice.  Oretga-Saenz et. al., (2006) have demonstrated 
that HO-2 KO mice show no impairment in their hypoxic chemotransduction capacity.  
Oxygen sensing in KO mice was not different from wild type (WT) mice when exposed  
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Figure 2. Proposed model for inhibition of BKCa channel during hypoxia. 
Under normoxic conditions, cellular heme is broken down into biliverdin, iron, and 
carbon monoxide.  Carbon monoxide is a (+) channel activator and makes certain the 
BKCa channel is open during normal oxygen levels.  During hypoxic conditions, the 
availability of O2 becomes limited and heme is no longer produced and CO production is 
greatly reduced.  The reduction in CO along with possible direct heme-dependent 






















to varying levels of hypoxia.  No differences were detected in dose-response curves from 
glomus cells between KO and WT mice.  These data suggest that the heme-oxygenase 
hypothesis cannot be fully supported, and the mechanisms outlined in the membrane 
hypothesis are not likely mediating O2-sensing within type I cells of the carotid body.  
Even though BKCa channels in mice are not O2-sensitive (Wyatt & Evans, 2007), the 
Oretga-Saenz data are still able to demonstrate that HO-2 does not play a role in hypoxic 
inhibition of oxygen-sensitive delayed rectifier Kv channels in type I cells of mice carotid 




 The mitochondrial hypothesis was first suggested after Heyman’s Nobel Prize 
winning experiments demonstrated a possible role for the mitochondria in hypoxic 
chemotransduction by the carotid body.  Heyman’s use of potassium cyanide produced 
similar effects to that of hypoxia in the carotid body (Heymans et. al., 1931), and later 
other investigators demonstrated that cyanide inhibited the mitochondrial oxidase 
cytochrome C (Wainio & Greenless, 1960; Van Buren et. al., 1972).  It is also known that 
physiological levels of hypoxia (20-60 mmHg) excite the carotid body (Lahiri et. al., 
1993) whereas in other cells that do not monitor oxygen levels, such as the dorsal root 
ganglion, PO2 levels must fall below 5 mmHg before oxidation of NADH is shown to 
accompany an increase in impulse discharge (Duchen & Biscoe 1992a, b; Jöbis, 1964).  
Thus, together with the fact that mitochondrial inhibitors and uncouplers increase carotid 
body activity, mimicking the effects of hypoxia (Krylov & Anichkov, 1968), these 
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studies have led to the hypothesis that O2-sensing by the CB type I cells may be possible 
through a mitochondrial cytochrome that has an unusually low O2-affinity (Mills & 
Jöbsis 1970, 1972).   
 Further support for a role of the mitochondria in O2-sensing has been shown by 
Mulligan et. al., (1981), whose work with oligomycin, which acts by binding ATPase in 
such a way as to block the proton channel causing inhibition of oxidative phosphorylation 
of ADP, demonstrated that intact oxidative phosphorylation is necessary for O2 
chemoreception to occur. In addition, Mulligan’s work also reported that oligomycin 
stimulates the CB chemoreceptor afferents and inhibits their response to further changes 
in arterial PO2. These data suggest that mitochondrial inhibitors not only mimic hypoxia 
but they stop further hypoxic effects at the cellular level.  Buckler and Vaughan-Jones 
(1998) also demonstrated that both hypoxia and mitochondrial uncouplers inhibit 
background K+ currents suggesting that the same channels may be involved in eliciting a 
response to both stimuli.  Additionally, Wyatt and Buckler (2004) showed that 
mitochondrial inhibitors such as rotenone, cyanide, myxothiazol and oligomycin mimic 
the effects of hypoxia by inhibiting background K+ currents, which led to membrane 
depolarization and voltage-gated calcium entry. Further work in this paper has also 
shown that in the presence of cyanide, rotenone or the mitochondrial uncoupler p-
trifluorometoxyphenyl hydrazone (FCCP), further excitation of isolated carotid body type 
I cells during hypoxia was prevented.  These results suggest that the mitochondria, does 




ATP in Hypoxic Chemotransduction 
Rat type I cells express background K+ channels that have biophysical and 
pharmacological properties resembling the TASK group of tandem-p domain K+ channels 
(Buckler, 1997; Buckler et. al., 2000).  The channels are active over a wide range of 
membrane potentials and are found to be the predominant K+ conductance at the resting 
membrane potential of isolated type I cells.  It is thought that modulation of the 
background K+ currents within type I cells is an important event in the process of 
chemotransduction during hypoxia and/or acidosis.  Background K+ currents have also 
been shown to be sensitive to mitochondrial metabolic inhibitors (Wyatt & Buckler, 
2004).  Inhibiting cellular metabolism results in decreased background K+ currents, 
which leads to membrane depolarization, voltage-gated Ca2+ entry and NT release 
(Buckler & Vaughan-Jones, 1998; Wyatt & Buckler, 2004; Varas et. al., 2007).  Previous 
studies have also shown that the response of these channels to hypoxic stimuli is absent 
when mitochondrial function is inhibited, suggesting a strong relationship between O2-
sensing and energy metabolism.  Williams and Buckler (2004) have shown that 
background K+ channel activity in excised membrane patches is enhanced in the presence 
of millimolar levels of ATP.  Further experimentation showed strong modulation of type 
I cell background K+ currents in excised inside-out patches in the presence of MgATP as 
well as other nucleotides such as, GTP, UTP, AMP-PCP and ATP-γ-S; indicating a 
possible tie between energy metabolism and cell excitability that is mediated via 
alterations in cytosolic, or sub-membrane levels of ATP (Varas et. al., 2007).  This work 
is in agreement with previous studies which have illustrated that excitation of type I cells 
through inhibition of background K+ channels, membrane depolarization, voltage-gated 
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Ca2+ entry and NT release is tied to mitochondrial metabolism (Williams & Buckler, 
2004).  It is possible there may be a link between changes in cytosolic ATP levels, the 
activity of background K+ channels and mitochondrial energy metabolism.  However, it 
still remains to be determined if inhibition of mitochondrial energy metabolism results in 
significant changes in cytosolic ATP in type I cells (Wyatt & Buckler, 2004).  Multiple 
nucleotides can activate background K+ channel activity (Varas et.al., 2007); therefore 
there may be other pathways that may also link mitochondrial energy metabolism to type 
I cell excitation.   
 Thus far it seems as if no consensus can be made regarding which hypothesis, the 
mitochondrial or membrane, actually plays a role in O2-sensing.  However, recent work 
indicates that the “energy-sensing’ enzyme, AMP-activated protein kinase (AMPK), may 
be a critically important kinase in the signal transduction cascade that couples the 
mitochondria to excitatory events in the type I cell plasma membrane (Evans et.al., 2005; 
Wyatt & Evans, 2007;Wyatt et.al., 2007; Evans et.al., 2009).   
 
 
AMPK Hypothesis  
 Evidence suggests that physiological levels of hypoxia inhibits oxidative 
phosphorylation of mitochondria in type I cells (Mills & Jöbsis, 1970, 1972; Duchen & 
Biscoe, 1992a), which in turn causes an increase in the cellular ratio of ADP/ATP 
(Figure 3).  Adenylate kinase converts two molecules of ADP to AMP and ATP to 
maintain ATP levels within the cell (Hardie & Hawley, 2001).  The consequent increase 
in AMP/ATP (Hardie & Hawley, 2001) activates AMPK, which has been reported to  
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Figure 3.  Proposed mechanism by which hypoxic inhibition of mitochondrial 
oxidative phosphorylation couples to type I cell depolarization and neurotransmitter 
release by activation of AMP-activated protein kinase (AMPK).  Arrows in red 
indicate inhibition.  Hypoxia (<60 mm Hg) inhibits oxidative phosphorylation of the 
mitochondria in type I cells, which leads to an increase in cellular ratios of ADP/ATP.  
Adenylate kinase converts two molecules of ADP into ATP and AMP in order to 
maintain ATP levels within the cell.  Increased AMP/ATP ratio activates AMPK, which 
has been reported to inhibit oxygen sensitive potassium channels leading to 
depolarization of type I cells.  Depolarization of the cells activates voltage-gated Ca2+ 
channels triggering an influx of calcium, release of neurotransmitters and an increase in 


























inhibit oxygen sensitive potassium channels causing a depolarization of type I cells 
(Evans et. al., 2005; Wyatt et. al., 2007; Ross et. al., 2011).  The depolarization activates 
voltage-gated Ca2+ channels triggering calcium influx and the release of 
neurotransmitters, causing an increase firing of the carotid sinus nerve (Wyatt et. al., 
2007).  This cascade of events suggests that AMPK can couple hypoxic inhibition of 
oxidative phosphorylation to transduction of membrane-restricted events in type I cells, 
which lends support to the mitochondrial hypothesis.  The cascade of events is the basic 
principle behind the AMPK transduction hypothesis (Figure 3).  This dissertation will 
test the hypothesis that AMPK couples hypoxic inhibition of oxidative phosphorylation 
to mouse type I cell excitation and therefore plays a key role in hypoxic 
chemotransduction by the carotid body and thus the acute hypoxic ventilatory response.  
AMPK α1 and AMPK α2 knockout mice (Jorgensen et.al., 2004; Viollet et.al., 2003b) 
will be used to examine this hypothesis. 
 
 
AMPK Structure and Function 
 AMPK, is a serine/threonine protein kinase that forms a heterotrimeric complex 
made up of an α catalytic subunit and 2 regulatory subunits, β and γ (Hardie, 2007).  
Each subunit can occur as an alternate isoform that is encoded by 2 or 3 genes (α1, α2, 
β1, β2, γ1, γ2, and γ3) and there are at least 12 different heterotrimer combinations 
possible from the various isoforms (Hardie & Hawley, 2001).  All 12 of the isoform 
combinations are capable of forming a complex (Hardie et. al., 2003) and diversity of 
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AMPK complexes occurs with alternative splicing and/or use of different promoters 
(Hardie, 2004).   
The N-terminus of the α subunit contains a conventional kinase domain (Figure 
4a), while the C-terminal end is necessary to form a complex with the β and γ subunits 
(Hardie, 2004). It appears there are distinct physiological differences between the α1 and 
α2 subunits (Violett et.al., 2003 b; Jorgensen et.al., 2004).   For example, it has been 
shown that mice lacking the α1 isoform of AMPK show no defect in glucose 
homeostasis, illustrated by a glucose tolerance test (B. Viollet and F Andreelli, 
unpublished data). The α1-/- mice also show a normal response to insulin and AICAR 
(Jorgensen et.al., 2004). By contrast, mice lacking the AMPK α2 isoform exhibit glucose 
intolerance and reduced sensitivity to insulin as well as AICAR-resistant (Jorgensen et. 
al., 2004; Viollet et.al, 2003b).  It has also been proposed that the AMPK α2 isoform but 
not the AMPK α1 isoform plays a major role in controlling skeletal muscle metabolism 
(Viollet et. al., 2003b). 
 In all eukaryotes, the β subunit (Figure 4b) is made up of an N-terminal region 
that is followed by two regions, originally named the kinase interacting sequence (KIS)  
 and association with SNF1 kinase (ASC) domains (Jiang & Carlson, 1997).  It was first 
thought the KIS domain was necessary for interaction with the α subunit, while the ASC 
domain interacted with the γ subunit.  However, it has been shown that only the ASC 
domain is necessary to give an active αβγ complex and the KIS domain is actually a 
glycogen-binding domain (GBD) (Hardie et. al., 2003; Hardie, 2004).  Each domain 
binds ATP with a lower affinity than AMP and the binding of ATP and AMP is mutually  
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Figure 4.  Basic domain structure of the α , β , and γ  subunits of AMP-activated 
protein kinase (AMPK).  A. Schematic of AMPK α subunit indicating the kinase 
region, the site of phosphorylation by upstream kinases and the site for auxiliary subunit 
binding.  B. Schematic of AMPK β subunit indicating possible glycogen binding domain 
and the site for αγ subunit binding.  C. Schematic of AMPK γ subunit indicating the 
crystathionine β-synthase (CBS) regions that form the two AMP/ATP binding ‘Bateman’ 
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exclusive, thus when ATP levels are high activation of AMPK will not occur (Hardie, 
2004, 2005). Activation of AMPK in mammals can occur via stressors such as hypoxia, 
heat shock, lack of nutrients, oxidative stress or metabolic poisoning (Hardie & Hawley, 
2001; Hardie, 2004).  Stress activation of AMPK results in a reduction in ATP 
consumption and promotes ATP production. 
AMPK is allosterically activated via 5’-AMP (Figure 5) but must be 
phosphorylated by 1 or more upstream kinases, such as LKB1 or calmodulin-dependent 
kinase kinasae β (CaMKKβ), at a threonine residue (Thr-172) within the α subunit kinase 
activation loop (Hardie et. al., 2005).  The most important AMPK upstream kinase 
appears to be LKB1 (Hawley et. al., 2003) because it is constitutively active.  
Phosphorylation of the Thr-172 residue within the α subunit, results in more than a 100-
fold increase in AMPK activation.  Binding of AMP to the 2 Bateman domains of the 
AMPK γ subunit (Scott et. al., 2004; Xiao et. al., 2007) activates the kinase by inhibiting 
the de-phosphorylation of Thr-172 (Sanders et. al., 2007), causing a switch to the active 
phosphorylated form.  Further allosteric activation, of the phosphorylated AMPK, by up 
to 10-fold, occurs when AMP binds to the γ subunit, thus the combination of the two 
events leads to an increase in activation of about 1000-fold (Suter et. al., 2006, Evans 
et.al., 2009).  ATP, AMP and ADP compete for the two sites on the γ subunit, and under 
normal physiological conditions ATP binds the inactive form of AMPK (Xiao et. al., 
2007).  The bound inactive form is more abundant versus the AMP bound active form 
(Evans et. al., 2009).  The AMPK activation mechanisms ensure it is highly  
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Figure 5. Schematic illustrating activation of AMP-activated protein kinase 
(AMPK) via upstream kinases and AMP binding.  AMPK is activated more than 100-
fold through phosphorylation at the Thr-172 residue on the α subunit via an upstream 
kinase such as LKB1 or calcium/calmodulin-dependent protein kinase kinase beta 
(CamKKβ).  LKB1 constitutively phosphorylates Thr-172 but binding of AMP to 2 
exchangeable sites on the γ subunits of AMPK also activates the kinase through 
inhibiting the de-phosphorylation of Thr-172.  AMPK is now switched to its 
phosphorylated form.  Binding of the AMP to the γ subunits results in further allosteric 
activation of the phosphorylated kinase by up to 10-fold, thus between the two events 
there can be up to a 1000-fold increase in activation.  Once AMPK is active it can 





















metabolically sensitive and even small changes in the ADP/ATP ratio can allow for 
AMPK activation without a large decrease in ATP levels (Hardie & Hawley, 2001).   
As previously mentioned, the most important upstream kinase, which plays a role 
in AMPK activation, is the tumor suppressor, LKB1 (Hawley et.al., 2003).  LKB1 is a 50 
kDa serine/threonine kinase and inactivating mutations in LKB1 result in a dominantly 
inherited cancer in humans known as Peutz-Jeghers syndrome (Woods et. al., 2003; 
Shaw et. al., 2004). LKB1 exists as a heterotrimeric complex with two accessory 
subunits, Ste20-related adaptor protein-α (STRADα) and mouse protein 25-α (MO25α) 
(Hawley et. al., 2003; Boudeau et. al., 2004). 
The two accessory proteins each have a closely related isoform, STRADβ and 
MO25β.  STRAD has a kinase-like domain that is related to the Ste20 protein kinase, 
however it is classified as a pseudokinase because it lacks certain residues found in active 
protein kinases (Baas et. al., 2003; Hawley et. al., 2003).  The complex, 
LKB1:STRAD:MO25, is only catalytically active when STRADα or STRADβ and 
MO25α or MO25β are available to form the heterotrimeric complex (Hawley et. al., 
2003; Boudeau et. al., 2004).  LKB1 appears to constitutively phosphorylate the Thr-172 
residue thereby activating AMPK (Hawley et. al., 2003; Shaw et. al., 2004).  Binding of 
STRAD to LKB1 is required for LKB1 to phosphorylate AMPK and is also required to 
anchor LKB1 to the cytoplasm.  MO25 is necessary for stabilization of the 
LKB1:STRAD complex (Hardie, 2005).   
 In addition to stressors, AMPK in many cells can also be activated via a Ca2+-
mediated pathway (Hawley et. al., 2005).  Stimuli, which lead to an increase in 
cytoplasmic Ca2+, result in the activation of the calmodulin-dependent protein kinase 
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(CaMKKβ).  CaMKKβ is an upstream kinase of AMPK and activation of CaMKKβ 
activates AMPK by phosphorylating the Thr-172 residue independent of AMP (Hawley 
et. al., 2005).  Work done by Woods et. al. (2005) provides strong evidence that 
intracellular Ca2+ acts as a second signaling pathway to activate AMPK. Instances that 
lead to an increase in calcium may result in ATP depletion because the Ca2+ pump(s) no 
longer have the energy needed to remove excess Ca2+ from the cytosol (Brini & Carafoli, 
2009). Conditions that activate AMPK through an increase in the AMP:ATP ratio also 
lead to an increase in intracellular Ca2+, i.e. oxidative stress, mitochondrial uncouplers, 
and exercise in muscle  (Patel et. al., 2001).  As a result, it is therefore possible that 
activation of AMPK may be a consequence of both ATP and Ca2+ mediated effects 
involving both LKB1 and CaMKKβ (Woods et. al., 2005).   
 
 
Pharmacological Manipulation of AMPK 
 Most data collected thus far with regard to the actions of AMPK has been 
obtained using pharmacological tools, such as the putative antagonist Compound C.  
However, it has been demonstrated that Compound C has off target effects, which are 
independent of AMPK inhibition (Emerling et. al., 2007).  Compund C has been shown 
to not only inhibit AMPK but also many other protein kinases (Bain et.al., 2007). Many 
experiments have also used the AMPK agonist, 5-aminoimidazole-4-carboxamide ribose 
(AICAR).  AICAR is taken up into the cells and converted to the AMP mimetic ZMP 
(AICAR monophosphate) and is able to activate AMPK without affecting the AMP:ATP 
ratio (Hardie et. al., 2003).  However, recent experiments utilizing AICAR have shown 
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that it may act as an inhibitor of Complex I of the mitochondrial electron transport chain 
(Guigas et. al., 2007), which affects cellular energetics by decreasing the synthesis of 
ATP and thus affecting the AMP:ATP ratio.  In addition, it is not always possible to 
differentiate between the specific actions of each of the catalytic subunit(s) through the 
use of drugs alone.  Activation of both AMPK α1 and AMPK α2 subunits may occur 
when using AICAR, thus it is not possible to determine the action(s) of the specific 
subunit(s) (Viollet et.al, 2003a).  Therefore, it is of great importance to be able to 
examine not only the role AMPK plays but also those subunit(s) combinations, which are 
being activated to get a better idea as to how the kinase functions in regards to the role it 
plays in hypoxia.  In order to gain further insight into the role of AMPK α1 and AMPK 
α2 subunits, research in this dissertation will focus on global AMPK α1 and global 
AMPK α2 knockout mice as well as targeted AMPK α2 knockout mice.   
 
 
Summary of Oxygen Sensing 
 To summarize, type I cells of the CB are the peripheral arterial chemoreceptors, 
which are activated not only by hypoxia, but also hypercapnia and extracellular acidosis.  
It has been known for over 70 years that the carotid body is an acute oxygen sensor and 
within the past 10-15 years or so it has been shown that the CB contains several classes 
of O2-sensitive K+ channels.  Inhibition of these channels leads to depolarization of type I 
cells, which allows entry of voltage-gated Ca2+ and NT release (Buckler & Vaughan-
Jones, 1994a; Peers & Buckler, 1995; Lopez-Barneo et. al., 2001).  However, the exact 
mechanism(s) which inhibits K+ channels during hypoxia in type I cells remains 
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controversial.  Recently, AMP-activated protein kinase has been identified as a 





 Sudden infant death syndrome (SIDS) is the number one leading cause of death in 
infants from 1 month to 1 year of age (Gauda et. al., 2007).  Carotid bodies are the key 
defense players in eliciting responses against hypoxia and hypercapnia.  Therefore, 
possible exposure to oxygen extremes before birth may result in an ineffective response 
by the PAC’s when faced with a hypoxic or hypercapnic event.  This may predispose a 
preterm infant to a higher risk of SIDS (Gauda et. al., 2007).  Thus, basic research into 
the mechanisms behind hypoxic chemotransduction and how carotid bodies are able to 
respond to hypoxia may prove beneficial for successful therapies and/or strategies for 
treatment of this disorder.  This information may also prove beneficial to other disorders, 
which are a result of prolonged or intermittent periods of hypoxia such as hypertension 
and sleep apnea (Prabhakar et. al., 2005).   
 Research laid out in this dissertation utilized global and targeted knockout mice to 
determine if and how the hypoxic ventilatory response (HVR) was altered when AMPK 
α1 or AMPK α2 subunits were knocked out.  If AMPK is important in oxygen-sensing in 
the type I cells of the carotid body, knocking out of the catalytic subunit(s) may result in 




Hypothesis:  AMP-activated protein kinase (AMPK) couples hypoxic inhibition of 
oxidative phosphorylation to type I cell excitation and therefore plays a key role in 
hypoxic chemotransduction by the carotid body and thus the acute hypoxic 
ventilatory response (HVR).  
 
Specific Aims: 
Specific Aim 1. Generate global knockout AMPK α1 and AMPK α2 mice as well as 
generate mice with targeted AMPK α2 subunits knocked out in tyrosine hydroxylase 
(TH) containing tissues, including the carotid body. 
 
Specific Aim 2. Test the hypothesis that AMPK is required for a complete hypoxic 
ventilatory response in mice using two-chamber plethysmography. 
 
Specific Aim 3. Test the hypothesis whether knocking out of AMPK alpha subunits 






Research Design and Methods 
 
Global Knockout Mice  
 In the early 1980’s scientists, Martin Evan, Oliver Smithies and Mario Capecchi 
developed the generation of a genetic “knockout” mouse (Thomas & Capecchi, 1987; 
Doetschman et.al., 1987; Waldman, 1992).  This breakthrough technology was the first 
of its kind to allow replacement or disruption of a specific gene using an inactive or 
mutated allele. Knockout mice allow scientists to selectively knockout or disable a 
specific targeted gene in embryonic cells, which allowed them to study the effect of the 
knocked out gene.  By the late 80’s, early 90’s, a “knock-in” mouse was finally 
developed in order to examine the effects of a mutated DNA sequence that is exchanged 
for an endogenous sequence without further disruption of the gene (Thomas et.al., 1986; 
Capecchi, 1994).  Knockout mice are valuable tools used today in various facets of 
biomedical and pharmaceutical research.  The research in this dissertation employed the 
use of knockout mice by utilizing mice with either the AMPK α1 or α2 subunits knocked 
out throughout the entire mouse because simultaneous knockout of both subunits is 
embryonic lethal (Viollet, et. al., 2003b).  The global AMPK α1 knockout mouse 
(AMPKα1-/-) used in experiments is designated B6.129/Sv-Prkaa1tm1Sbj/Orl, it is a knock-
in of beta-galactosidase/Neomycin (=GEO) gene fusion.  In order to inactivate the 
AMPK α1 catalytic domain, a replacement vector was made with 7kb of ES-129-derived 
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genomic fragment and a selection cassette, which deleted part of the catalytic AMPKα1 
subunit from amino acids 97-157 (Jorgensen et. al., 2004) (Figure 6).   The global 
AMPK α2 KO mice (AMPK α2-/-) are designated B6.129/Sv-Prkaa2tm1.1Vio/Orl, and were 
obtained from a conditional knockout (alpha2 floxed mouse) crossed with an Ella-Cre 
deleter mouse. The AMPK α2 genomic clones were isolated after screening a mouse 129 
strain genomic library (Stratagene, La Jolla, CA).  The targeting construct was produced 
by flanking exon C, which encodes the AMPK α2 catalytic subunit with loxP sites for 
Cre recombinase and inserting a phosphoglycerol kinase (PGK) promoter-driven 
neomycin selection cassette that was flanked by an additional loxP site (Viollet et.al., 
2003b) (Figure 7).  The targeted construct was linearized and electroporated into 129/Sv 
MPI-I embryonic stems cells.  Cells expanded from the targeted clones were injected into 
C57BL/6 mice.  The heterozygous offspring were then bred with a “deleter” Ella-Cre 
transgenic mouse, in which Cre was expressed in the the germline, to produce AMPK 
α2+/- mice (Holzenberger et.al., 2000).  These mice were used to confirm the role(s) 
AMPK α1 and/or AMPK α2 subunits play in response to hypoxia by the carotid body. 
The breeding plan for generating the global AMPK KO experimental animals is shown in 
Figure 8a.  PCR was used to confirm correct genotype for both global AMPKα1 and 
AMPKα2 KO mice (Figure 8b). AMPK α1+/- and AMPK α2+/- mice were obtained from 
the European Mutant Mouse Archive (EMMA) with the kind permission of Dr. B. 
Viollet.  These animals were bred onto a mixed C57BL/6J:129-1x background to provide 
homogeneity with all the other knockout mice used in the Wyatt laboratory. AMPK α1+/- 
and AMPK α2+/- mice were then bred to provide -/- mice and their +/+ controls.   
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Figure 6.  Generation of AMPKα1 Knockout Mice. A schematic (not to scale) 
illustrating the genomic structure of the AMPK α1 wildtype allele (top), the AMPKα1 
gene-targeting construct that contains a promoterless IRES-βGeo cassette (middle), and 
the targeted gene (bottom).  E, EcoRI digestion; IRES, internal ribosomal entry site; 
βGeo, β-galactosidase and neomycin phosphtransferase fusion gene; pA, 
































Figure 7.  Generation of AMPKα2 Knockout mice.  Schematic (not to scale) 
illustrating the genomic structure of the AMPK α2 wild-type allele, AMPK α2 gene-
targeting construct, AMPK α2 targeted allele, and AMPK α2 null allele.  Squares 
indicate loxP sites and H’s indicate HindIII restriction sites.  C, exon encoding the 

































Figure 8. A. Global mouse breeding plan.  Shown is the breeding plan to obtain global 
AMPK α1 and AMPK α2 knockout mice for use in plethysmography and cellular 
studies. 
B. PCR bands for wild type, heterozygous and homozygous AMPK α1 and AMPK 




















Figure 8. (A) 
  
 












Mice were tail clipped at 5 days of age and genotyped as follows (all primer sequences 
were obtained from Dr. B. Viollet) (Table 1). 
AMPKα1 wildtype allele, forward: KO+ AGC ACA GTA CCT GGT ATC TTA 
TAG G, reverse: KO- GGA CTT ATT ACT AAA CAG ACC TCT G (yields 329bp band 
for WT allele).  AMPKα1 deleted allele, forward: GEO+ ACC AGA AGC GGT GCC 
GGA AAG CTG G, reverse: GEO- TGT AGT CGG TTT ATG CAG CAA CGA G 
(yields 466bp band for deleted allele).  Tail DNA and primers were added to GoTaq mix 
(Promega) and PCR cycled as follows: 94°C, 4 min, 94°C, 45 sec, 35 cycles; 57°C, 45 
sec, 35 cycles; 72°C, 60 sec, 35cycles; 72°C, 7 min; 4°C hold. 
 AMPKα2 wildtype allele, forward: loxF1 GCT TAG CAC GTT ACC CTG GAT 
GG, reverse: loxR1 GTT ATC AGC CCA ACT AAT TAC AC (yields 200bp band for 
WT allele).  AMPKα2 deleted allele, forward: same as for WT, reverse: koTneoR GCA 
TTG AAC CAC AGT CCT TCC TC (yields 600bp band for deleted allele).  Tail DNA 
and primers were added to GoTaq mix (Promega) and PCR cycled as follows: 94°C, 
4min; 94°C, 20sec, 35 cycles; 58°C, 20sec, 35 cycles; 72°C, 30 sec, 35 cycles; 72°C, 7 
min; 4°C hold.   
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Table 1.  Primers used for genomic PCR of global AMPK α1, AMPK α2, and TH-
targeted knockout mice shown with melting temperatures (TM) and amplicon size 
(SIZE). 


















5’ CTTTCCTTCCTTTATTGAGAT 3’ 












5’ GCATTGAACCACAGTCCTTCCTC 3’ 
5’ GCTTAGCACGTTACCCTGGATGG 3’ 












5’ GCTTAGCACGTTACCCTGGATGG 3’ 
5’ GTTATCAGCCCAACTAATTACAC 3’ 











Targeted Knockout Mice 
 It is possible that globally knocking out AMPK α subunits may have an inhibitory 
effect on the hypoxic ventilatory response via a mechanism mediated by something other 
than the carotid body.  Recent data reveal that AMPK has multiple ion channel targets 
(Dallas et. al., 2009; Evans et. al., 2009; Kreneisz et. al., 2009) and by knocking out 
AMPK in the brain, it may affect the path that signals from the carotid body and 
integrates with the central mechanisms of ventilatory control.  Thus, it is possible by 
knocking out AMPK there may be alterations in central neuronal firing such that it could 
directly modulate the mechanisms that pattern inspiration (Doi & Ramirez, 2008) in 
addition to any CB mediated actions.  To minimize the possible central effects of 
knocking out AMPK, experiments focused on targeting AMPK α2 knockout to neurons 
containing tyrosine hydroxylase (TH).  By targeting to dopaminergic and nor/adrenergic 
neurons, AMPK α2 subunits were deleted from the carotid body type I cells but were 
spared in much of the central processing hypoxic peripheral input (Gozal et.al., 2000; 
Takakura et.al., 2006).  However, some central TH containing neurons can modulate the 
carotid body chemoreflex (Zhang & Mifflin, 2007; Viemari, 2008), thus caution would 
be needed when interpreting the data.   
 As mentioned previously, to minimize the possible central effects of knocking out 
AMPK, the experiments illustrated in this dissertation have focused on targeting AMPK 
α2 knockout to neurons containing tyrosine hydroxylase.  Tyrosine hydroxylase is the 
rate-limiting enzyme in the biosynthesis of catecholamines (Lindeberg et. al., 2004).  
Through targeting of dopaminergic and nor/adrenergic neurons, the AMPK α2 subunits 
should be knocked out in the carotid body type I cells but remain untouched in much of 
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the central processing of hypoxic peripheral input (Gozal et. al, 2000; Takakura et. al., 
2006).  One area of the brain that may be affected by the knockout of AMPK α2 and is 
believed to be involved in the hypoxic response includes the locus coeruleus (LC). The 
LC is a cluster of noradrenaline containing neurons found adjacent to the fourth ventricle 
in the pontine brainstem (Berridge and Waterhouse, 2003).  It is the principle site for the 
production of noradrenaline and has many projections that innervate almost all regions 
within the central nervous system (CNS), which include the nuclei responsible for 
thermoregulation and cardiorespiratory function (Bockstaele et. al., 1999).  Evidence 
suggests that excitation or inhibition of noradrenergic structures such as the LC can 
modulate the cardiorespiratory responses to peripheral chemoreceptor activation 
(Koshiya & Guyenet, 1994; Perez et.al., 1998).  It is possible that by targeting AMPK 
knockout to TH containing neurons the activity of the LC is changed and, in theory, this 
could blunt the HVR (Zhang & Mifflin, 2007).  However, work done by Biancardi et.al., 
(2010) used selective bilateral chemical lesions in the LC to demonstrate that under 
hypoxic conditions, chemical lesions of the LC had no affect on minute ventilation, mean 
arterial pressure, heart rate or core body temperature.  Therefore they were able to show 
that the noradrenergic neurons of the LC do not play a role in cardiorespiratory control 
and thermoregulation during acute hypoxia.  
 Genetic manipulation through the use of the Cre-lox recombination system has 
proven to be extremely beneficial in elucidating gene function in many experimental 
organisms, especially mice (Le & Sauer, 2001).  Through the use of the Cre-lox system it 
is now possible to generate knockout and targeted knockout animals without causing 
death. In many cases knocking out a certain gene can lead to embryonic death and thus 
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result in an inability to acquire adult animals to study the effect of the gene later in life 
(Sauer & Henderson, 1988; Holzenberger et. al., 2000; Le & Sauer, 2001).  The Cre-lox 
recombination makes it possible to study the effects of gene knockout in adult organisms 
as well as the effects of a tissue specific gene knockout.  Cre recombinase is a single 38 
kDa protein necessary for the catalyzation of DNA recombination between two 34 base 
pair loxP sites.  Each loxP site contains two 13-basepair palindromes separated by an 8-
basepair spacer that confers directionality to the site.  The region of DNA that is flanked 
by the two loxP sites is said to be “floxed” (Le & Sauer, 2001).  The loxP sites contain 
specific sites for Cre binding, which surround a specific DNA sequence where 
recombination may occur.  Recombination occurs in cells that express Cre and contain 
loxP sites.  Cre recombinase cuts the double stranded DNA at the specified loxP sites and 
the strands are then re-joined with DNA ligase (Sauer & Henderson, 1988).  The 
sandwiching of DNA between the 2 loxP sites is termed “floxed,” which is a contraction 
of “flanked by lox.” The use of a conditional targeted gene knockout mouse model 
(Figure 9) has allowed for examination of the function of a specific gene in a targeted 
tissue without affecting the expression of the gene in non-targeted tissue (Lindeberg et. 
al., 2004).  
 In order to effectively target knockout of AMPK α2 activity in the carotid body, 
mice conditional for the expression of floxed AMPK α2 were crossed with mice 
expressing Cre recombinase under a TH promoter (B6;129X-1THtm(cre)Te/Kieg), 
(Lindeberg et. al., 2004). Mice conditional for AMPK α2 allows for the specific gene to 
be knocked out in a specific organ or tisssue versus the entire mouse. AMPK α2 should 
be ablated in the catecholaminergic TH-expressing type I cells of the TH-Cre+/+FloxedFl/Fl  
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Figure 9.  Schematic illustrating TH-targeted AMPKα2 knockout to the carotid 
body.  The Cre mouse is under a tyrosine hydroxylase promoter and was crossed with a 
LoxP (Floxed) mouse.  The floxed mouse has the gene of interest, AMPK α2, flanked on 
either side by a loxP site. When the TH-cre mouse is bred with the floxed mouse, cells 
with active Cre recombinase cuts the double stranded DNA at the specified loxP sites and 
the strands are then re-joined. Any cells containing tyrosine hydroxylase will have 
AMPK α2 knocked out including the carotid body. Cells lacking active Cre recombinase 
do not have AMPK α2 knocked out.  Recombination occurs only in cells that express Cre 
and contain both loxP sites.  Cre recombination allows one to study the knockout of a 




















mice (Figure 10). Lindeberg et. al., (2004), has been able to show the TH-Cre (B6;129X-
1THtm(cre)Te/Kieg) mice can be successfully crossed with a β-galactosidase (LacZ) 
reporter strain wherein the reporter gene is activated via Cre recombination.  The double 
heterozygous offspring showed good correlation between LacZ expression and TH-
expressing cells illustrating efficient genomic recombination in the TH-expressing cells.  
Therefore, crossing the AMPK α2 floxed mice with the TH-Cre mice should remove 
AMPK α2 from TH-expressing cells including the carotid bodies. To increase the 
efficiency of the targeted knockout of AMPK α2, F2 generation male TH-Cre+/+FloxedFl/- 
mice (Figure 10) were crossed with female TH-Cre+/+FloxedFl/- mice. The F1 generation 
mice from this cross are shown in Figure 11. This genotype should provide knockout of 
the AMPK α2 subunits in the targeted TH-cells (Sakamoto et. al., 2005). By using the 
refined breeding strategy illustrated in Figure 11, the percentage of viable experimental 
mice increased to 100% by giving mice that are all homozygous for TH-Cre and either 
homozygous or heterozygous for the flox gene. Mouse DNA genotyping via PCR was 
done on tail clippings at 5 days of age and genotyped using specific primers for the Cre 
transgene and floxed AMPK α2 (all primer sequences were obtained from Dr. B. Viollet 
(Figure 12, Table 1)). 
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Figure 10.  Targeted knockout breeding strategy.  Shown is the initial breeding plan to 
obtain TH-targeted AMPK α2 knockout in the carotid body type I cells.  Crossing the 






















Figure 10.  
 
 *TH-Cre+/+FlxFl/Fl    Successful Target 
 *TH-Cre+/+FlxFl/-    Sucessful Target 
 
 *TH-Cre-/-FlxFl/Fl    Same as Fo (i.e. control) 
 *TH-Cre+/-FlxFl/-     
 
 *TH-Cre+/-FlxFl/-    Same as F1 (i.e. control) 
 *TH-Cre-/-FlxFl/-     
 
 *TH-Cre+/+Flx-/-    Same as Fo (i.e. control) 
 *TH-Cre+/-Flx-/-  
  





Figure 11.  Refined targeted breeding strategy.  The targeted breeding strategy shown 
in Figure 10 will result in a low percent of TH-targeted AMPK α2 knockouts.  Crossing 
the F2 TH-Cre+/-FloxFl/- mice from Figure 10, will yield 100% experimentally viable 





















Figure 11.  
 
   












Figure 12.  PCR primer bands for TH-Cre and Floxed2.  Gel confirms correct 


















































 Ventilatory in all wildtype, global AMPK α1 and AMPK α2 knockouts as well as 
TH-targeted AMPK α2 KO mice was measured using pressure plethysmography 
(Stunden et.al., 2001).  All experiments were conducted at room temperature (22-24°C).  
Each mouse was placed into a 100cc plexiglass Respiromax plethysmography chamber 
(Figure 13) (Columbus Instruments, Columbus, OH).  A tail rod moved the mouse 
forward in the chamber securing it and preventing it from backing up.  Mice were set in a 
prone position allowing their snouts to emerge through an inflatable latex cuff into the 
head chamber.  The cuff was inflated (maximum 20 P.S.I.) giving an airtight seal around 
the snout of the mouse.  Pressure changes within the body chamber as a result of the 
animals’ respiration were measured through a transducer and this signal was digitized at 
200Hz data points per second using a Respiratory Function program (Columbus 
Instruments, Columbus, OH).  Information was displayed and stored in a computer for 
statistical and graphical analysis.  Oxygen flow passing into the head chamber was 
controlled with a Pegas 4000 (MF) Gas Mixer and Gas Mixer System Software 
(Columbus Instruments, Columbus, OH). Respiration rates (RR) and tidal volume (VT) 
were measured in all wildtype, global and TH-targeted knockout mice using a Columbus 





Figure 13.  Mouse two-chamber plethysmography unit.  Schematic of Respiromax 







































 The head chamber was supplied with humidified 21% O2 and 0% CO2 gas mixture 
(balanced Nitrogen) at a flow rate of ~0.8L/min to establish a baseline recording for 3 
minutes. To obtain peak acute hypoxic responses, oxygen levels were decreased to 12% 
or 8% for 3 minutes and then returned to 21% for a final 3 minutes.  Respiration rates and 
tidal volume data were monitored, collected and analyzed using the Respiromax/tidal 
volume computer program, version 2.06.  Data was taken from 40-50 seconds of stable 
breathing during the peak response of each change in O2 level, 21%, 12%, 21% as well as 
21%, 8%, 21%.  In addition, data was taken from 40-50 seconds of stable breathing 
during exposure to 0%, 7%, 0% CO2 at a flow rate of 1L/min for 2 minutes at each level.  
Data containing artifacts caused by mouse movement were excluded from analysis.  All 
animals were awake during data acquisition and were weighed before testing (25-35 
grams).   
 
 
Isolation of Type I Cells 
 All cellular experiments were conducted using type I cells isolated and 
enzymatically dissociated from the carotid bodies of mice.  The carotid bifurcations of 
the mouse were removed and the carotid bodies were isolated under a dissecting 
microscope.  Isolated CB’s were placed in ice-cold oxygenated phosphate buffered saline 
(low Ca2+ and Mg2+).  Carotid bodies were then placed into low Ca2+ and Mg2+ saline 
with 0.040% collagenase Type I (22µ/mg, Worthington Biochemical Corporation) and 
0.025% trypsin Type I (10100µ/mg, Sigma) and put into a 37°C incubator for 20 minutes 
for dissociation. Carotid bodies were then teased apart using forceps and incubated for an 
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additional 7 minutes.  Cells were then centrifuged at 730 rpm (200g) for 5 minutes and 
supernatant was removed.  Cells were re-suspended in Hams F12 (Sigma) supplemented 
with 10% fetal bovine serum (Biowest) and then centrifuged for an additional 5 minutes.  
Type I cells were plated onto 10mm poly-d-lysine (Sigma) coated (0.1mg/ml) cover slips 
and incubated for at least 2 hours to allow the type I cells to settle and stick to the cover 
slips.  Cells were used within 8 hours of isolation because cell viability greatly decreases 




 Isolated type I cells for AMPKα2 +/+ or -/- were processed separately using the 
same reagents.  Cells were processed on the same day at the same time and every effort 
was made to treat the two groups of tissue identically.  Coverslips with attached type I 
cells were fixed by immersion in methanol at -20° C for 20 minutes.  Cells were then 
permeablized by 3x5min washes with 0.3% triton X-100 (Sigma) in phosphate buffered 
saline (PBS).  Type I cells were given another 3x5min wash with blocking solution (1% 
donkey serum, 0.3% triton X-100 in PBS) to limit non-specific binding of the specific 
anti-AMPK α2 receptor antibodies.  Anti-AMPK α2 1° antibodies (Kinasource, UK) 
were diluted 1:750 with blocking solution, added to the coverslips and incubated at 4° C 
for 16 hours.  Cells were also stained with a rabbit anti-mouse tyrosine hydroxylase 
antibody (1:2000, Sigma) to assist identification of type I cells.  Following incubation 
with the 1° antibodies, coverslips were washed 4x5min with blocking solution and then 
incubated for 1 hour, at room temperature in the dark with 1:200 dilution of Rhodamine 
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Red-X-conjugated affinipure donkey anti-rabbit IgG (Jackson Immunoresearch) and 
FITC-conjugated affinipure donkey anti-sheep IgG 2° antibody (Jackson 
Immunoresearch, 1:200).  Coverslips were then washed for 5x5min with PBS before 
being inverted and attached to microscope slides with hard setting anti-fade mountant 
(2.4g Mowiol 4-88, 6g glycerol, 6ml H2O, 12ml 0.2M Tris buffer pH 8.5, 2,5% 
diazobicyclo-octane) containing 4’, 6-diamidino-2-2-phenylindole dihydrochloride 
(DAPI, 1mg ml-1) for visualization of type I cell nuclei.  For controls, 1° antibody was 
omitted during this procedure.  Images were acquired using a DeltaVision microscope 
system (Applied Precision) on an inverted Olympus IX71 microscope with an oil 
immersion, x63 magnification, 1.4 n.a. objective and Coolsnap HQ CCD camera 
(Photometrics).  Multiple z-sections (focal depth 0.28 µm, z-step 0.25µm) were taken 
through individual cells.  Images were deconvolved on-line via Softworx software 
(Applied Precision).  Deconvolved images of these identically processed cells were then 
viewed using identical intensity parameters in Softworx and intensity line plots were 
constructed by appending a line across the center of the cell of interest.  Pixel intensity 
was reported along the line and allowed comparisons between staining in AMPK α2+/+ 
and AMPK α2-/- type I cells (Figure 14).   
 
Genomic Polymerase Chain Reaction 
 Genomic DNA was isolated from 5-7 day old tail tips using DNeasy® tissue kit 
(Qiagen) according to manufacture’s instructions.  Genomic polymerase chain reaction 
(genomic PCR) analysis was performed using 1.0 µl of genomic DNA, 6.7 µl double  
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Figure 14. AMPK α2 staining in mouse carotid body type I cells from wildtype and 
AMPK α2 knockout mice.  A. Staining in wildtype AMPK α2 mouse type I cell.  Green 
is AMPK α2 and blue is DAPI staining for the nucleus.  The white scale bar is 10 µm and 
the red line indicates the location of the intensity plot shown in panel C.  B. Reduced 
staining shown in AMPK α2 KO mice type I cells.  Green is AMPK α2 and blue is DAPI 
staining for nucleus.  The red line indicates the location of the intensity plot shown in 
panel C and D.  C and D. Intensity line plots from panels A and B respectively.  Data is 
represented in thousands of units.  Staining was done on AMPK α1 WT and KO mice 
type I cells but was not successful.  Lack of success in the AMPK α1 mice may have 






































distilled water, 1.6 µl of 10 µM Primer TH-5, 1.6 µl of 10 µM Primer TH-3, 1.6 µl of 10 
µM Primer Cre-UD and 12.5 µl 2X GoTaq Green™ (Promega) mix.  Genomic PCR was 
performed as follows: a 5 minute denaturation step at 92°C, 35 cylces of 45 seconds at 
92°C, 45 seconds of annealing at 56°C, and 1 minute extension at 72°C, followed by a 
 final extension for 7 minutes at 72°C.  Genomic PCR products were separated on a 1.5% 
agarose gel, and visualized using ethidium bromide and UV light.  Images were captured 




 Isolated type I cells were loaded with Fura-2AM (5µM, Invitrogen) in an 
extracellular solution containing (in mM): NaCl, 140; KCl, 4.5; CaCl2, 2.5; 
MgCl2, 1.0; glucose, 11.0; HEPES, 20.0; pH 7.4 with NaOH, for 30 minutes, at room 
temperature (22-24°C) in the dark. Fura-2AM, is a membrane permeable, dual 
wavelength, fluorescent dye. Once inside the type I cells, the –AM portion of the dye is 
cleaved off leaving behind the charged Fura-2, which is calcium-sensitive, and binds free 
Ca2+ resulting in a change in its fluorescent properties. Cover slips with Fura-2 attached 
loaded cells were washed with extracellular solution for 15 minutes before being 
mounted in a chamber (0.4 ml) and perfused at 8 ml/min-1 with a standard bicarbonate 
buffered solution (in mM; NaCl, 117; KCl, 4.5; CaCl2, 2.5; MgCl2, 1.0; glucose, 11.0; 
NaHCO3, 23.0) gassed with 5% CO2 balanced air  (35-37°C, pH 7.4).  Cells were 
visualized with a CFI super fluor 40x oil immersion objective.  Fura-2 was excited with 
50 ms exposures to 340nm and 380nm light at 0.2-0.5 Hz using a Lambda 10-3 filter 
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wheel (Sutter) and emitted fluorescence measured at 470-550nm using a CoolSNAP HQ2 
CCD camera.  Neutral density filters of 0.7 optical densities were placed in the excitatory 
light path to reduce any photodamage to cells (Burlon et.al., 2009).  Data acquisition and 
analysis was controlled using Metafluor 7.1.2. imaging software (Molecular Devices).  
Only cells that maintained a low resting intracellular Ca2+ level and had a strong and 
reversible increase in fluorescence ratio to 20% CO2 were used for further experiments.  
The robust response signifies a healthy cell, which has not been damaged by enzyme 
digestion (Burlon et. al., 2009; Thompson et. al., 2010; Thompson & Wyatt, 2011). Type 
I cells were then exposed to a hypoxic solution (10 mm Hg/10 torr) and the ratio of  
[Ca2]i was measured. Calcium ratio data was reported as a ratio instead of absolute 
calcium values because the system could not be calibrated properly with ionomycin. In 
order to properly calibrate for absolute calcium the following equation would be used: 
[Ca]=Kd(Sf2/Sb2)(Rexp-Rmin/Rmax-Rexp) where Kd is the affinity of Fura-2 for calcium, Sf2 
is the intensity at 380nm for calcium free, Sb2 is intensity at 380nm for bound calcium, 
Rexp is measured experimental ratio, Rmin is 0 Ca ratio and Rmax is Ca saturated ratio.  The 
oxygen tension reached in the bath was measured using an OxyMicro oxygen sensor 
(WPI). The level of hypoxia reached in the bath over one minute was 10 torr, which is a 




Basal metabolic rates (BMR) were assessed on all wildtype, global AMPK α1 and 
AMPK α2 knockout mice.  Oxygen consumption and carbon dioxide excretion were  
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Figure 15.  Recording Bath Oxygen Tension.  Figure illustrates the oxygen level 
reached in the bath for calcium-imaging experiments.  The level of oxygen (~10 torr) 








measured with open flow respirometry using oxygen and carbon dioxide gas analyzers 
(S-3A/I, Applied Technologies, Pittsburgh, PA, USA; CD-3A, Applied Technologies, 
Pittsburgh, PA USA,  respectively). Flow rate (0.248-0.257 L/min) was controlled with a 
4100 Series flow meter (TSI Inc., Shoreview, MN). All mouse weights were noted before 




O2 were corrected as standard temperature and pressure under dry 
conditions (STPD). Mice were placed in a 14cm x 10.2cm x 7.6cm plastic metabolic 
chamber (Figure 16) and allowed to acclimate to their surroundings for 30 minutes 
before the experiment began.  All metabolic experiments were run for 30 minutes and 
data were collected every 5 minutes unless there was a change of more than 0.05 in 
consumed oxygen or excreted carbon dioxide and then data were collected and the time 
point was noted.  Chamber temperature and barometric pressure were measured for each 
trial and were on average 27 ºC and 736 mmHg, respectively. Oxygen and carbon dioxide 
analyzers were calibrated each day before experiments were run to ensure accurate 
readings.   
 
Data Analysis and Statistics 
 Values in figures and text are reported as means ± S.E.M.  Significance was 
determined where appropriate using unpaired Student’s t-Tests with P<0.05 defined as a 
significant difference.  Further statistical guidance will be sought from the Wright State 




Figure 16. Schematic illustrating the metabolic chamber set up. A. Metabolic 
chamber, B. Filter, C. Flow meter, D. Carbon dioxide analyzer with drying column, E. 



















































Ventilatory Response of Global AMPK α1 and AMPK α2 Knockout and TH-
targeted Knockout Mice to Hypoxia  
 It is well known that the carotid bodies respond to changes in the PO2 of the blood 
and act to produce an increase in ventilatory response upon exposure to a hypoxic 
situation (Heymans et.al., 1930).  A two-chamber plethysmography unit was used to 
determine the role of AMPK in the hypoxic response.  Resting or baseline breathing rates 
were examined first then mice were exposed to a hypoxic challenge.  Figure 17 shows 
the baseline breathing rates for all wildtype mice (n=9), global AMPK α1 knockout mice 
(n=20) and global AMP α2 knockout mice (n=22).  The frequency (f), or respiration rate, 
in breaths/minute was not significantly different between the WT (269.66±17.23 
breaths/min) and global knockout mice (α1KO, 253.91±14.10; α2KO 273.51±14.73 
breaths/min) at rest (Figure 17, i.).  There was no difference in tidal volume (VT, µl/g) 
between the WT (7.12±0.90 µl/g) and global knockout α1 (6.38±0.34 µl/g) or α2 
(6.82±0.61 µl/g) mice at rest (Figure 17, ii). In addition, at rest, minute ventilation (VE, 
ml/min/g) was slightly attenuated in the AMPK α1 knockout mice (1.56±0.08 ml/min/g) 
compared to the WT (1.91±0.24 ml/min/g) and AMPK α2 (1.84±0.15 ml/min/g) mice but 
the difference was not significant.  Upon exposure to 12% oxygen, the percent change  
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Figure 17. Histograms showing baseline ventilatory responses in wildtype, AMPK 
α1 and AMPK α2 knockout mice.  (i.) Resting Breathing, (ii.) Tidal Volume, (iii.) 


































in frequency, which is the difference in respiration rate between 12% O2 and 21% O2 was 
not significantly different between the WT (8.62±2.04%) or α1 knockout mice 
(9.21±2.26%).  The AMPK α2 knockout mice (2.37±2.76%) showed a reduced percent 
change in respiration rate but it was not significant due to wide variability (Figure 18, i).  
Due to wide variability the percent change in tidal volume, difference in tidal volume at 
12% O2 and 21% O2, showed no significant difference between the WT (2.32±8.29), 
global α1 knockout (-1.74±4.18%) or AMPK α2 KO mice (2.75±3.12%) (Figure 18, ii).  
Overall, there was no significant difference between the % increase in minute ventilation 
seen with the WT, (11.53±10.29%) global AMPK α1, (6.34±3.56%) and AMPK α2 
knockout  (4.99±3.69%) mice during a 12% oxygen challenge (Figure 18, iii). 
 In order to determine the acute ventilatory response to a more severe hypoxic 
challenge, baseline breathing rates were collected, then mice were exposed to 8% 
oxygen, which corresponds to 25,000 feet (7620 meters) and is an extreme level of 
hypoxia.  Figure 19, illustrates the baseline breathing for the ventilatory response at rest 
in the control (n=21) and global AMPK α1 knockout (n=33) mice before exposure to 8% 
oxygen.   The frequency in breaths/minute between the WT (249.22±8.06 breaths/min) 
and α1-/- mice (275.59±7.16 breaths/min) at rest was slightly elevated in the knockout 
mice but was not significant (Figure 19, i).  Tidal volumes of the WT (9.1±0.52 µl/g) 
mice were slightly elevated at rest versus the AMPK α1 KO (6.4±0.34 µl/g) mice but 
were not significant (Figure 19, ii).  Resting minute ventilation was significantly 
attenuated in the global AMPK α1 KO (1.73±0.08 ml/min/g; unpaired  
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Figure 18.  Percent Increase in Breathing upon exposure to 12% O2. (i.) Percent 
change in frequency (F), (ii.) Percent change in tidal volume (VT), (iii).  Percent change 
in minute ventilation (VE) in AMPK α1 and AMPK α2 KO mice when exposed to 12% 







































Figure 19. Histograms showing baseline ventilatory responses in wildtype and 
Global AMPK α1 Knockout Mice. A.(i.) Resting respiratory rate (F), (ii.) Tidal volume 
(VT) and (iii.) Significant decrease in resting minute ventilation (VE) in AMPK α1 KO 









































Student’s t-Test, p<0.005) when compared to the WT mice (2.25±0.12 ml/min/g) (Figure 
19, iii).  When the WT and global AMPK α1 were exposed to 8% O2 the percent change 
in frequency of the AMPK α1-/- mice (5.34±1.06%; unpaired Student’s t-Test, p<0.004) 
was significantly less compared to the WT mice (13.89±3.04%) (Figure 20, i).  The 
percent change in tidal volume of the α1 KO (10.01±2.38%) mice was elevated 
compared to the WT (4.79±2.64%) mice but was not significant (Figure 20, ii).  Finally, 
the percent change in minute ventilation at 8% O2 in the WT (19.04±4.12%) mice was 
slightly elevated when compared to the knockout mice (15.73±2.54%) but was not 
significantly different (Figure 20, iii).   
   The AMPK α2 KO mice were also used in plethysmography experiments to 
determine their acute hypoxic ventilatory response.  Figure 21 shows the baseline 
breathing rates at rest of the WT (n=21) and global AMPK α2 knockout mice (n=18).  
The respiration rate or frequency of the WT (249.22±8.06 breath/min) mice was slightly 
lower versus the AMPK α2-/- mice at rest (308.84±9.74 breaths/min) but it was not 
significantly different (Figure 21, i).  When comparing the tidal volume of the knockouts 
to the WT (9.1±0.52 µl/g) mice, the AMPK α2-/- (5.3±0.39 µl/g; unpaired Student’s t 
Test, p<0.00001) mice had a significantly attenuated tidal volume vs. the WT (Figure 21, 
ii).  In addition, there was a significant decrease in minute ventilation in the global 
AMPK α2 KO (1.62±0.09 ml/min/g; unpaired Student’s t test, p<0.0005) mice compared 
to the WT (2.25±0.12 ml/min/g) mice at rest (Figure 21, iii).  
 When the WT and AMPK α2 KO mice were exposed to 8% oxygen, there was a 
significant decrease in the percent change in respiration rate between the AMPK α2-/-  
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Figure 20. Percent change in ventilatory parameters in response to 8% hypoxia.  (i.) 
Significant decrease in the percent change in respiratory rate in the AMPK α1-/- mice 
compared to wildtype (p<0.004), (ii.) Percent change in tidal volume, (iii.) Percent 








































Figure 21. Histograms showing baseline ventilatory responses in wildtype and 
Global AMPK α2 Knockout Mice.  (i.) Resting Breathing, (ii.) Significant decrease in 
tidal volume in AMPK α2-/- mice compared to wildtype (p<0.0001), (iii.) Significant 
decrease in resting minute ventilation in AMPK α2 KO mice compared to WT 






































Figure 22.  Percent change in ventilatory parameters in response to 8% hypoxia in 
WT and global AMPK α2 KO mice.  (i.) Significant decrease in the percent change in 
respiration frequency in AMPK α2 KO mice compared to WT (p<0.04), (ii.)  Percent 
change in tidal volume, (iii.)  Significant attenuation (~80%) in % change in minute 
ventilation in AMPK α2-/- mice when exposed to 8% O2 compared to WT (p<0.005) 





































 (6.09±1.53%; p<0.04) and the WT (13.89±3.04%) mice (Figure 22, i). The percent 
change in tidal volume observed in the AMPK α2-/- mice (-1.79±2.93%) decreased 
compared to the WT (4.79±2.64%) mice but was not significant (Figure 22, ii).  Finally, 
upon exposure to 8% O2 there was a significant attenuation of % change in minute 
ventilation in the global AMPK α2 KO (3.80±2.62%; unpaired Student’s t-Test, p<0.005) 
mice by about 80% when compared to the WT (19.03±4.12%) mice (Figure 22, iii).  
It is possible that knocking out AMPK globally may have an inhibitory effect on 
the HVR through a mechanism mediated by something other than the carotid body.  In 
order to try and minimize possible central effects to knocking out AMPK globally, mice 
that potentially had knockout of AMPK in tissues containing tyrosinse hydroxylase, 
which includes the carotid bodies were used.  The AMPK α2 subunits in the carotid 
bodies of these targeted knockout mice should be deleted, thus sparing much of the 
central processing hypoxic peripheral input (Gozal et.al., 2000; Takakura et.al., 2006). 
The ventilatory response of WT (n=21), Floxed controls (FlFl/Fl; n=20), and AMPK α2 
TH-targeted KO mice (THCre+/+FlFl/Fl; n=13) were examined to determine if a central 
effect of global AMPK α2 knockout was removed.  
  Figure 23 illustrates the baseline breathing rates for the WT, floxed controls and 
TH-targeted KO mice.  There was no difference in the respiration rate between WT 
(249.22±8.29) mice compared to the flox control mice (259.7±7.30) at rest; however, the 
targeted KO (303.92±6.19) mice showed a significant increase in respiration rate 
compared to wildtype mice (249.22±8.29; unpaired Student’s t-Test, p<0.00004) at rest 
(Figure 23, i). When comparing the tidal volume at rest of the WT, flox controls, and  
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Figure 23.   Histograms showing baseline ventilatory responses for wildtype, Flox 
control (FlFl/Fl) and TH-Targeted knockout mice (ThCre+/+FlFl/Fl).  (i.) Significant 
increase in resting breathing in TH-targeted KO mice compared to WT (p<0.0004), (ii.) 
Significant decrease in tidal volume in flox control mice and TH-targeted KO mice 
compared to WT mice (FloxFl/Fl, p<0.0068; TH-targeted, p<0.008), (iii.) Significant 
decrease in resting minute ventilation in flox control mice compared to WT (p<0.02) 




































targeted KO’s (Figure 23, ii), there was a significant decrease in the flox controls 
(7.4±0.31 µl/g; unpaired Student’s t-Test, p<0.0068) compared to the WT mice (9.1±0.52  
µl/g) as well as a significant attenuation in the tidal volume of the targeted KO 
(6.98±0.48 µl/g; unpaired Student’s t-Test, p<0.008) when compared to wildtype mice at 
rest.  The flox control mice also showed a significant decrease in resting minute 
ventilation (1.90±0.068 ml/min/g; unpaired Student’s t-Test, p<0.02) when compared to 
the WT mice (2.25±0.122 ml/min/g), but there was no significant difference between the 
WT and ThCre+/+FlFl/Fl (2.12±0.153 ml/min/g) mice at rest (Figure 23, iii). 
After exposure to 8% oxygen the flox controls (31.45±5.58%) showed no 
significant difference in the percent change in respiration rate compared to the wildtype 
mice (23.73±7.30%). There was a significant attenuation in the percent change in 
respiration rate in the TH-targeted KO (-2.81±12.23; unpaired Student’s t-Test, p<0.007) 
mice vs. the WT (31.45±5.58%) (Figure 24, i). Both the flox control mice (0.98±0.21%) 
and targeted KO (1.03±0.31%) mice showed a slightly elevated percent change in tidal 
volume when compared to the wildtype (0.33±0.22%) but neither were significantly 
different (Figure 24, ii).  In addition, there was no significant difference in the percent 
change in minute ventilation between the flox controls (0.446±0.079%), ThCre+/+FlFl/Fl 
(0.250±0.051%) and the wildtype (0.367±0.053%) mice  (Figure 24, iii) when exposed 
to 8% oxygen.      
 Thus, during exposure to 12% O2 AMPKα1 and AMPK α2 mice did not show a 
significant difference in their hypoxic ventilatory response when compared to the 
wildtype mice.  As a result the level of hypoxia was decreased to 8%.  Baseline minute  
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Figure 24. Percent change in ventilatory parameters in response to 8% hypoxia in 
WT, TH-targeted KO (ThCre+/+FlFl/Fl) and Flox control (FlFl/Fl) mice.  (i.) Significant 
decrease in the percent change in respiration frequency in TH-targeted KO mice 
(p<0.007), (ii.)  Percent change in tidal volume, (iii.)  Percent change in minute 
ventilation (VE) in flox controls and TH-targeted KO mice when exposed to 8% O2 






























ventilation rates for both AMPKα1 and AMPK α2 mice were significantly less compared 
to their wildtype counterparts.  During exposure to 8% oxygen AMPKα1 and AMPK α2  
KO mice showed a significant attenuation in the percent change in frequency, as well as 
α2 KO mice having a significant decrease in the percent change in minute ventilation 
(~80% less).   
 
Ventilatory Response of Global AMPK α1 and AMPK α2 Knockout and TH-
targeted Knockout Mice to Hypercapnia 
 It has been shown that increasing inspired CO2 is a well established respiratory 
stimulus (Haldane & Priestly, 1905) mediated in part, by the carotid body (Gonzalez, 
et.al., 1994). It is believed that TASK channels play a role in the CO2-sensing ability 
within the type I cells of the carotid body.  Therefore the ventilatory response of the mice 
to hypercapnia was done as control experiments to illustrate that AMPK plays no role in 
how the type I cells of the carotid body sense changes in carbon dioxide. Figure 25 
illustrates the ventilatory response of the WT (n=15), global AMPK α1 (n=29), and 
AMPK α2 (n=22) knockout mice at resting breathing (0% CO2). The AMPKα1 KO 
(222.23±11.00 breaths/min) mice have a slightly attenuated resting respiration rate 
compared to the WT (254.75±12.59 breaths/min) but was not significant, whereas the 
AMPK α2 KO mice have a significantly elevated resting respiration rate (291.1±11.94 
breaths/min; unpaired Student’s t-Test, p<0.048) (Figure 25, i). There was no difference 
in tidal volume between the AMPK α1-/- (5.96±0.23 µl/g) mice compared to the wildtype 
(6.32±0.28 µl/g) at rest but the AMPK α2-/- mice (4.4±0.25 µl/g; unpaired  
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Figure 25. Histograms showing hypercapnic ventilatory responses in wildtype, 
AMPK α1 KO and AMPK α2 KO mice. A. (i.) Significant increase in resting 
frequency in AMPK α2 KO mice compared to WT (p<0.048).  (ii.) Significant decrease 
in tidal volume in AMPK α2 KO mice compared to WT at rest (p<0.00013).  (iii.) 
Significant decrease in resting minute ventilation in AMPK α1 KO mice and AMPK α2 
KO mice compared to WT at rest (α1-/-, p<0.004; α2-/-, p<0.01; WT, n=15; AMPK α1-/-, 






















Student’s t-Test, p<0.0001) had a significant decrease compared to the WT mice (Figure 
25, ii).  Both the global AMPK α1 KO (1.30±0.054; unpaired Student’s t-Test, p<0.004) 
mice and AMPK α2 KO (1.28±0.079; unpaired Student’s t-Test, p<0.010) mice had a 
significant decrease in minute ventilation at rest compared to the WT (1.60±0.09 
ml/min/g) (Figure 25, iii).   Upon exposure to 7% CO2 the WT (20.06±6.13%) and 
AMPK α1-/-  (17.98±3.47%) mice did not show any significant difference in percent 
change in respiration rate (Figure 26, i).  The AMPK α2-/- (8.91±1.88%) mice showed a 
decrease in the percent change in respiration rate during 7% CO2 but it was not 
significant (Figure 26, i).  The percent change in tidal volume was not significantly 
different between the WT (10.36±3.31%), α1-/- (8.41±2.44%) or α2-/- (9.06±2.01%) mice 
during 7% CO2 (Figure 26, ii).  Both the AMPK α1 KO (26.82±3.29%) mice and AMPK 
α2 KO mice (18.42±2.38%) showed a slight decrease in percent change in minute 
ventilation (Figure 26, iii) compared to the WT mice (32.10±7.59%) when exposed to 
7% CO2 but it was not significant. 
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Figure 26.  Percent change in ventilatory response when exposed to 7% CO2 in WT, 
AMPK α1 and AMPK α2 KO mice.  (i.) Percent change in frequency, (ii).  Percent 
change in tidal volume, (iii).  Percent change in minute ventilation in AMPK α1 KO and 








































Metabolic rates for Wildtype, Global AMPK α1 KO and Global AMPK α2 KO 
Mice During Steady State.  
 Minute ventilation rates at rest in both global AMPK α1 and AMPK α2 knockout 
mice were significantly attenuated as a result, metabolic experiments were run in order to 
rule out a metabolic difference between the knockout and WT mice.  Rates for mean 
oxygen consumption (V
.
 O2), carbon dioxide excretion (V
.
 CO2) and respiratory exchange 
ratio (R) for wildtype, AMPK α1 KO and AMPK α2 KO mice are shown in Table 2. 
There were no significant differences between oxygen consumption in the wildtype 
(82.34±6.62), AMPK α1 KO (80.70±7.28) and AMPK α2 KO (98.48±2.58) mice 
(Figure 27, A).  AMPK α1 KO (62.87±2.60) and AMPK α2 KO (65.46±2.12) mice 
showed slightly elevated levels of V
.
 CO2 compared to wildtype (61.73±3.14) but were not 
significant (Figure 27, B).  The respiratory exchange ratio, which is the ratio of carbon 
dioxide produced/oxygen consumed, showed no significant difference between the 
wildtype (0.79±0.03), AMPK α1 (0.81±0.05) and AMPK α2 KO (0.66±0.02) mice 
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CO2 (ml/min/Kg) Respiratory 
Exchange Ratio  
Wildtype 82.34±6.62 61.73±3.14 0.79±0.03 
AMPK α1 KO 80.70±7.28 62.87±2.60 0.81±0.05 
AMPK α2 KO 98.48±2.58 65.46±2.12 0.66±0.02 
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Figure 27. Metabolism Histograms showing metabolic rate in wildtype, AMPK α1-/- 
and AMPK α2-/- mice.  A. No significant differences between mice in the rate of oxygen 
uptake (V
.
 O2).  B. No significant difference between mice in the amount of CO2 produced 
(V
.
 CO2).  C. No significant difference in mice in the ratio of carbon dioxide produced in 


















Figure 27.  
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Problems with the Targeted Knockout Mouse  
To ensure that AMPK α2 knockout was targeted to TH-expressing tissue the 
adrenal medulla and cortex were removed from TH-targeted mice and examined for the 
presence of an AMPK signal.  The adrenal medulla expresses tyrosine hydroxylase and 
therefore the AMPK signal in this tissue should be absent or knocked out in a TH-
targeted KO mouse as Cre recombinase will be active.  By contrast, the adrenal cortex 
tissue does not contain tyrosine hydroxylase and should give a +/+ AMPK signal in a 
targeted KO mouse.  Figure 28 is a PCR gel showing the presence or absence of the 
AMPK signal in the medulla and cortex for a WT mouse, an AMPK alpha 2 global KO 
mouse and a TH-targeted KO mouse.  The WT mouse shows a +/+ signal for AMPK in 
both the medulla and cortex, which is what one would expect.  When examining the 
AMPK α2 global KO mouse, AMPK is not present in either the  adrenal medulla or 
adrenal cortex and this is also to be expected since AMPK is globally knocked out 
throughout the entire mouse. In the targeted KO mouse there is a -/- signal in the medulla 
for AMPK (top band), which is to be expected because the medulla is TH-positive tissue. 
The bottom +/+ band in the medulla is a residual flox band because there are both TH 
positive and TH negative tissue in the medulla. For example, chromaffin cells are TH 
positive whereas blood vessels are TH negative.  However, when looking at the TH-
negative cortex the top band is also showing a -/- signal for AMPK (Figure 28, red 
circle), this should NOT occur because the cortex does not contain TH-positive tissue.  
To ensure the reason for observing AMPK knockout in the adrenal cortex was not 
due to contamination with medulla fragments, adrenal cortex tissue was taken from 
outside the adrenal gland, which does not contact the medulla.  The same results were  
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Figure 28.  PCR of Targeted Knockout Adrenal Medulla (M) and Cortex (C) 
Looking for Presence of AMPK α2 Signal.  The wildtype mouse (WT) shows the 
presence of AMPK (+/+) in both medulla (M) and cortex (C).  The global KO mouse 
(α2ko) has AMPK α2 (-/-) knocked out in both medulla and cortex because it is a global 
KO vs. a targeted KO.  The targeted KO mouse (target ko) shows knockout of AMPK α2 
(-/-) in the medulla (top band) and the bottom band is a residual flox signal from non-TH 
tissue.  The targeted KO mouse also shows knockout of AMPK α2 (-/-) in the cortex. 
Red circle indicates lack of AMPK in cortex, which should not occur because the cortex 
does not contain tyrosine hydroxylase and should not be cut out in the targeted KO 


























found each time: TH-negative cortex showed AMPK α2 knockout.  This lack of AMPK 
signal in the cortex was the first indication there was a potential targeting problem with 
the targeted KO mice.   
It was discovered that two main problems presented themselves with regard to the  
 targeted KO mice (Figure 29).  The first issue was a loss of the flox signal in the 
targeted KO mice. Primers designed to identify whether a mouse was +/+, -/+ or -/- for 
floxed AMPKα2 failed to produce an identifiable band. Figure 29 (issue 1) shows a 
single targeted knockout mouse that is +/+ for Cre but does not have a Flox signal.  The 
lack of a flox signal could possibly be explained if somehow the animal had lost all 
AMPK α2.  Indeed the AMPK α2 signal from the tail was  -/- in this mouse. The fact that 
the AMPK signal is -/- and the flox signal is absent would indicate this mouse was a 
global knockout instead of a TH-targeted mouse.  If this mouse was a true targeted KO 
mouse, AMPK would still be present because the tissue for the PCR was taken from the 
tail where no TH-positive tissue should be found. 
 There was also a second issue that arose with the targeted knockout mice.  The 
ideal targeted knockout mouse is +/+ for Cre and +/+ for Flox, which appears to be the 
case for the single targeted KO mouse shown in Figure 29 (issue 2).  However, when 
looking for the AMPK signal in this mouse it was absent which should not be the case 
because tail tissue does not contain tyrosine hydroxylase.   Knockout of AMPK in the tail 
tissue should only occur if Cre was sending the knockout throughout the entire mouse 
versus just TH-positive tissue.  It is possible that Cre is not targeting to  
 
 103 
Figure 29.  PCR gel illustrating the two main issues in regards to the TH-targeted 
knockout mice.  Issue 1: Loss of flox signal in the targeted knockout mouse. DNA from 
tail tissue shows the mouse is +/+ for Cre but the flox signal is absent and the mouse is -/- 
for AMPK α2.  Red circles indicate loss of flox signal and -/- band for AMPK α2.  Issue 
2: Gel seems to illustrate the preferred targeted knockout mouse genotype (+/+ for Cre, 
+/+ for Flox), but shows a negative signal for AMPK, which should not occur because 










































just TH-positive tissues but to other tissue as well.  AMPK should only be knocked out in 
TH-positive tissue if the cre is correctly targeted/expressed.   
As a result of the two aforementioned genotyping issues (spontaneous global KO 
and mis-targeting of cre) the parents of the targeted knockout mice were examined to 
determine if the parent’s genotype could explain the unexpected results that were 
obtained.   Figure 30 examines the presence or absence of Cre, Flox and AMPK in the 
father (F), mother (M) and offspring (O) of a single targeted knockout mouse.  The father 
and mother were +/- for Cre and produced a +/+ Cre offspring.  The parents were +/- for 
Flox but the flox signal was lost in the offspring, which prompted further examination of 
the father, mother and offspring for the presence of AMPK.  Both parents were +/+ for 
AMPK and the offspring was -/- for AMPK α2, which is not genetically possible since 
both parents were +/+ for AMPK α2.  It appears as if the offspring was a global knockout 
mouse instead of a targeted KO mouse.  Mice that showed a loss of the flox signal were 
not used for any experiments, so no plethysmography or imaging data were collected 
from these mice.   
Next, the parents of a mouse that appeared to be an ideal targeted AMPK KO 
were examined for the presence of Cre, Flox and AMPK.  Upon examination of the PCR 
gel shown in Figure 31 both the father and mother were +/- for Cre and Flox which gave 
an offspring that was +/+ for Cre and +/+ for Flox.  The offspring of this cross appeared 
to be an ideal targeted KO (ThCre+/+FloxFl/Fl) and the mice were used in plethysmography 
experiments.  However, when the presence of AMPK α2 was looked for, the offspring 
showed a negative signal while the parents were +/+ for AMPK α2.  If  
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Figure 30. PCR gel showing the presence or absence of Cre (C), Flox (F) and AMPK 
α2 (A) in the Father (F), Mother (M) and Offspring (O) of a single TH-targeted 
knockout mouse in regards to Issue 1.  Both father and mother are +/- for Cre and flox 
giving an offspring that is Cre+/+ but lacks a flox signal. Both parents are +/+ for AMPK 
but the offspring shows a -/- signal for AMPK indicating the offspring is a global 
knockout.  The first red circle indicates a lack of flox signal in the offspring while the 
second circle indicates a lack of a negative signal in the parents for AMPK, making it 








































Figure 31. PCR gel showing the presence or absence of Cre (C), Flox (F) and AMPK 
α2 (A) in the Father (F), Mother (M) and Offspring (O) of a single TH-targeted 
knockout mouse in regards to Issue 2: Both father and mother are +/- for Cre and flox 
giving an offspring that is Cre+/+Flox+/+, which is the ideal genotype for the targeted KO.  
Both parents are +/+ for AMPK α2 but the offspring shows a negative signal for AMPK, 
which if the offspring were a true targeted KO AMPK α2 should be present because tail 









































this mouse was truly a targeted KO mouse an AMPK α2 signal should be seen because 
the tissue used for the PCR came from the tail.  The tail does not contain tyrosine 
hydroxylase and thus the AMPK signal should be present whether the animal is a targeted 
knockout or a wild type.   
It seems as if Cre was targeting not only to TH-tissue but was cutting out AMPK 
in other tissues as well. The presence of AMPK in these animals was not examined 
before using them for plethysmography experiments since they were +/+ for Cre 
and +/+ for flox, which lead me to believe they were indeed a targeted knockout.  As 
a result of the genotyping issues that have come about, plethysmography data collected 
from the targeted animals is not reliable because it is not known if AMPK α2 was 
knocked out in tissues other than TH-containing tissue.   
 To reiterate, to check that the targeted mice were indeed targeting knockout 
properly, the adrenal medulla and adrenal cortex were screened for the presence  
of an AMPKα2 signal.  Knockout of AMPK α2 was shown in the medulla, which is to be 
expected due to the presence of tyrosine hydroxylase.  However, knockout was also seen 
in the cortex, which is an issue because the cortex does not contain TH-positive tissue.   
Another issue was the loss of the flox signal in the targeted knockout giving offspring 
that appeared to be global knockouts, which cannot be explained and thus these mice 
were not used in plethysmography or calcium imaging.   
The final targeting issue came about when it appeared the perfect targeted 
knockout mouse had been generated because it was +/+ for Cre and +/+ for flox but 
showed knockout of AMPK α2 in tail tissue.  Again, data from these mice were not 
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useable due to the uncertainty of whether or not AMPK α2 knockout had been targeted 
appropriately.   
 
Calcium Imaging 
Type I Cells Response to Hypoxia from Global AMPK α1 and AMPK α2 Knockout 
Mice  
 Functional carotid body type I cells are known to depolarize in response to 
hypercapnia or hypoxia leading to voltage-gated calcium entry (Buckler & Vaughan-
Jones, 1993, 1994a,b) and neurotransmitter release.  Isolated type I cells from wildtype 
and AMPKα1 KO mice were subject to hypercapnic (20% CO2) and hypoxic (~10 torr) 
solutions and levels of intracellular calcium were measured. The AMPK α1 KO type I 
cells had a strong hypercapnic response but a mixed response to hypoxia.    Figure 
32(A.) illustrates a hypoxic response in an AMPK α1 KO type I cell whereas Figure 
32(B.) shows a type I cell from an AMPK α1 KO mouse with little to no response to 
hypoxia.   
 Calcium imaging results from AMPK α2 KO mice type I cells show they respond 
nicely to hypercapnia (20% CO2) but do not show a hypoxic (~10 torr) response as seen 
in the wildtype cells.  Wildtype mice type I cells (Figure 33A) respond robustly to HC as 
well as hypoxia.  The AMPK α2 KO type I cells have a slightly attenuated hypercapnic 
response about 28% less versus the wildtype cells (Figure 33B) and also show a 
significant decrease in hypoxic response.  The lack of hypoxic response in the AMPK α2 
KO type I cells is illustrated by a significantly reduced [Ca2+]i ratio (p<0.003) compared 
to the wildtype cells (Figure 33C).    
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Figure 32. Ca2+ Imaging Results from Global AMPKα1 Knockout Mice (A.) A 
global AMPK α1 KO mouse type I cell response to hypercapnia (HC) and hypoxia.  (B). 
Type I cell from a global AMPK α1-/- mouse response to (HC) but little to no response to 
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Figure 33. Ca2+ Imaging Results from Global AMPK α2 Knockout mice (A.) 
Wildtype mice type I cells respond to hypercapnia (HC) and hypoxia.  (B). Global 
AMPK α2-/- mice respond to (HC) but have impaired ability to transduce a hypoxic 
stimulus compared to WT mice.  (C.) Significant decrease in cells response to hypoxia in 























AMPK and Pharmacological Tools 
 Previous work attempting to establish the role of AMPK has been largely 
pharmacological and many of these agents have proven to have some non-specific or off-
target effects independent of AMPK, which suggests caution must be used if utilizing 
these compounds to examine the role of AMPK in hypoxic chemotransduction. For 
example, Emerling, et.al. (2007) have shown that Compound C, a known inhibitor of 
AMPK, was able to suppress the hypoxic activation of HIF-1 in cells lacking AMPK α1 
or AMPK α2.  These data also show Compound C inhibits respiration independent of 
AMPK illustrating an off-target effect.   Furthermore, Compound C is known to be a 
more potent inhibitor of TWELVE other kinases besides AMPK (Bain et.al., 2007). 
Caution should also be used when interpreting data collected using the AMPK 
agonist, AICAR as Guigas et.al. (2007) showed cellular respiration was inhibited in rat 
hepatocytes that lacked either AMPK α1 or AMPK α2 subunits when AICAR was used. 
The inhibition of respiration in these knockout mice by AICAR was mediated 
independent of AMPK α subunits.   To get around the possible uncertainties observed 
with pharmacological tools, global knockout mice were utilized in this dissertation to 
characterize the role of specific AMPK α subunits to provide further concrete evidence 
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for AMPK’s role in the transduction of hypoxic signaling by the carotid body and the 
acute hypoxic ventilatory response.     
 
 
Global Knockout Mice and Hypoxic Response to Plethysmography  
 Global knockout mice have been the foundation for research in this project.  The 
ideal knockout mouse for these experiments would have been to knockout both AMPK 
α1 and AMPK α2 subunits in the same animal but this is embryonically lethal (Viollet et. 
al., 2003b) and thus not feasible.  A double knockout would have guaranteed that AMPK 
had no catalytic activity and would have allowed for examination of the role each alpha 
subunit may play. The double knockout model would have avoided the possibility that 
knocking out one of the subunits (i.e. α1) would result in compensation by the other (α2) 
and vice versa.  A double KO mouse is not possible thus; mice used in the experiments 
had either the AMPK α1 or AMPK α2 subunit knocked out globally.  The global 
knockout mice allowed for examination of the role the AMPK alpha subunit(s) played in 
response to a hypoxic challenge.    
Upon exposure to acute hypoxia the carotid bodies become stimulated resulting in 
an increase in minute ventilation which peaks in the first few minutes (Powell et. al., 
1998; Smith et.al., 2001).  Minute ventilation then declines to a point that is still higher 
than at normoxia depending on the level of hypoxia. This decrease in minute ventilation 
is termed hypoxic ventilatory decline (HVD) (Figure 34). Hypoxic ventilatory decline 
generally occurs after a prolonged exposure to hypoxia (5-30 minutes) (Powell et.al., 
1998). In order to avoid HVD in the plethysmography experiments conducted in this 
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Figure 34.  Hypoxic Ventilatory Decline (HVD).  Time course of ventilatory response 
to hypoxia.  Peak aHVR is the peak acute hypoxic ventilatory response, HVD is the 
hypoxic ventilatory decline.    
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dissertation, all hypoxic challenges were limited to 3 minutes and plethysmography data 
were taken from the peak hypoxic response. All wildtype and global AMPK α1 and 
AMPK α2 knockout mice were first exposed to 12% oxygen to examine the role AMPK 
played in the hypoxic response (Figure 18).  At 12% oxygen the global AMPK α2 KO 
mice showed a decrease in percent change in respiration rate as well as minute ventilation 
and the AMPK α1 KO mice showed a decrease in percent change in tidal volume and 
minute ventilation but none of these were significantly different from the WT responses.  
It appeared that 12% oxygen was not a sufficient stimulus to produce a significant 
hypoxic response between knockout and wildtype mice, thus the hypoxic challenge was 
switched to a more robust hypoxic challenge of 8% oxygen.   
At rest, the AMPK α1 KO mice showed no difference in frequency or tidal 
volume when compared to wildtype (Figure 19), however, the AMPK α1 KO mice did 
show a significant attenuation (p<0.0005) in minute ventilation compared to WT mice. 
Upon exposure to 8% oxygen (Figure 20) the AMPK α1 KO mice had a significant 
decrease in the percent change in frequency of breathing (P<0.004).  However, there was 
no significant difference in the percent change in tidal volume and no significant 
difference in percent change in minute ventilation in the AMPK α1 knockout when 
compared to WT. Even though there is no significant difference between the KO and WT 
with regard to % change in minute ventilation, it does appear that knocking out the 
AMPK α1 subunit may have some affect on the response to hypoxia, as there is a 
significant decrease in the frequency response of the KO mice to hypoxia.   
In the AMPK α2 KO mice there was a slight increase in frequency of breathing at 
rest but it was not significant when compared with wildtype mice.  In addition these KO 
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mice showed a significant decrease in tidal volume (p<0.00001) and minute ventilation 
(p<0.0005) at rest (Figure 21) compared to the wildtype mice.  When the AMPK α2 KO 
animals were exposed to 8% oxygen there was a significant decrease in the percent 
change in frequency (p<0.04) as well as a significant attenuation in the percent change in 
minute ventilation (p<0.005).  The % change in minute ventilation was about 80% less 
when compared to the WT mice at 8% oxygen (Figure 22), which demonstrates that 
knocking out AMPK α2 subunits affects the acute hypoxic respiratory response of mice.  
These data also lend further support that AMPK plays a role in the acute HVR.   
The plethysmography data from the global knockout mice show a significant 
decrease in percent change in frequency of breathing during exposure to 8% oxygen in 
both the global AMPK α1 and AMPK α2 knockout mice, however there was no 
significant percent change in tidal volume. This observation warrants further discussion.  
There was also a significant decrease in the percent change in minute ventilation in the 
AMPK α2 KO mice.  It has been reported in animals where carotid body resection has 
occurred the entire hypoxic ventilatory response is gone however, if there is tonic sinus 
afferent discharge from the carotid body a partial ventilatory response to hypoxia can 
take place (Smith et.al., 2010; Hill et.al., 2011).  This partial ventilatory response is 
possible due to specialized neurons, which function as central oxygen-sensors and are 
found in the Pre-Bötzinger complex of the respiratory network of the brain stem (Hill 
et.al., 2011).  As long as the carotid sinus nerve offers some afferent discharge, the Pre- 
Bötzinger is able to compensate for the loss of oxygen-sensing by the carotid bodies 
(Bissonnette, 2000; Hill et.al., 2011; Smith et.al., 2010; Curran et.al., 2000).  Thus in 
terms of a hypoxic response, the carotid body is necessary for an increase in breathing 
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frequency but not tidal volume (Bissonnette, 2000; Hill et.al., 2011). It appears as if the 
frequency response to hypoxia is under the control of the peripheral chemoreceptors 
whereas response to tidal volume can be mediated by central chemoreception, which 
could help explain the lack of significant tidal volume response reported in the 
aforementioned data.    
However, a potential methodological issue must also be discussed.  The range of 
tidal volume values reported in this dissertation is quite variable and a few appear to be 
less than tidal volume values reported in the literature (Trapp et.al., 2008). Another 
possible explanation for the range of tidal volume values collected is the 
plethysmography equipment set up. If the head of the mouse was not properly held in 
place by the inflatable cuff air could possibly have leaked out at this point. Thus tidal 
volume values would be reduced but frequency readings would remain accurate.  In order 
to address the potential issue with the tidal volume values in regards to equipment set up, 
use of an unrestrained whole body plethysmography unit might prove beneficial.  
Unrestrained whole body units would get rid of the animal head/body restraint issue and 
there is plenty of data in the literature to compare values.  The only downfall to the 
unrestrained whole body unit is that it costs around $50-60,000, which at the time was 
not a feasible purchase.   
 
 
TH-targeted Knockout Mice and Hypoxic Response to 8% Oxygen 
In addition to the global knockout mice, mice were also used which targeted 
knockout of the AMPK α2 subunit to tyrosine hydroxylase containing tissue that 
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included the carotid body.  Targeted knockout mice were used to try and minimize 
possible central effects of knocking out AMPK by focusing on targeting AMPK α2 
knockout to neurons containing TH. The targeted knockout would also minimize 
peripheral effects that may have occurred in the global AMPK KO mice.  
Knocking out AMPK subunits in the brain may affect the communication line 
between the carotid body and the central mechanisms of ventilatory control. Therefore, 
AMPK α2 subunits were deleted in TH-positive cells, which includes carotid body type I 
cells but was spared in much of the brain regions that process the hypoxic peripheral 
input (Gozal et.al., 2000; Takakura et.al., 2006).  It has been postulated that potential 
sites for convergence between the carotid body and the brain stem include the nucleus 
tractus solitarii (NTS) and retrotrapezoid nucleus (RTN) (Blain et.al., 2010).  RTN 
neurons receive excitatory input from afferents of the carotid chemoreceptors which 
bypass the respiratory network and are believed to involve a glutamatergic neuron found 
in the NTS (Takakura et.al., 2006).  Neurons of the commissural NTS (commNTS) are 
activated by carotid body activity and innervate the RTN via projections that are mainly 
glutamatergic.  Because these neurons are glutamatergic in nature and not tyrosine 
hydroxylase positive, these areas of the brain should not be affected in the targeted KO 
mice.  
Some of the central TH neurons however can affect the chemoreflex of the carotid 
body (Zhang & Mifflin, 2007; Viemari, 2008).  Certain central noradrenergic neural 
structures of the brain such as A1, A2, A5 and A6 cell groups, are activated upon 
stimulation of the peripheral chemoreceptors.  These structures innervate and possibly 
modulate neurons found in the caudal nucleus tractus solitarius (cNTS), which is the 
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location of the first central projections from the carotid bodies (Zhang & Mifflin, 2007).  
A2 neurons specifically receive sensory input from the peripheral chemoreceptors, which 
suggests they play a role in modulating the respiratory chemo-reflex (Viemari, 2008).  It 
is also believed that A6 neurons are among the earliest born neurons (Lauder & Bloom, 
1974) and therefore may have some role in the maturation of neural processes including 
that of the respiratory network (Viemari, 2008).   
Since these norepinephrine neurons express tyrosine hydroxylase and possibly 
affect the carotid body chemoreflex (Zhang & Mifflin, 2007; Viemari, 2008), data from 
the TH-targeted knockout mice must be interpreted with caution.   Knock out of AMPK 
α2 subunits in these TH-positive neurons may affect the signal sent from the brain to the 
respiratory network once the carotid bodies are stimulated.  
Data were collected from the TH-targeted KO mice in order to examine their 
hypoxic ventilatory response (Figure 24).  When exposed to 8% oxygen, the TH-targeted 
KO mice (ThCre+/+FlFl/Fl) had a significantly attenuated percent change in frequency 
(p<0.03) compared to the WT and flox control mice.  However, there was no significant 
difference between the percent change in tidal volume and percent change in minute 
ventilation among the groups.  There were some concerns raised with these data since the 
global AMPK α2 KO mice showed a significant attenuation in minute ventilation during 
hypoxia but the targeted knockout minute ventilation values were not significant. A 
possible explanation is the TH-targeting may have not worked properly.  As mentioned 
earlier, issues arose in regards to the targeting of AMPK α2 KO in TH-containing tissues 
as to the actual location of the knockout. The mice appeared to be the perfect targeted 
knockout because they were +/+ for Cre and +/+ for flox but lacked the presence of 
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AMPK α2 in tail tissue (Figure 29, issue 2). The lack of AMPK α2 in the tail is 
problematic because the tail does not contain TH-positive cells, thus AMPK should not 
be knocked out. Knockout of AMPK in the tail would occur only if Cre was somehow 
sending the knockout throughout the entire mouse versus just the TH-positive cells. 
Lindberg et.al., (2004) were able to demonstrate that cre-mediated site- specific 
recombination was successful by using a marker gene along with the loxP sites to detect 
recombination.  These data illustrate that cre recombinase does in fact work therefore 
something in our mouse cre recombinase system is not working properly. Thus, 
plethysmography data collected from the TH-targeted KO mice cannot be reliably 




Global AMPK Knockout Mice Hypoxic Response and Calcium-Imaging  
To provide further support to the attenuated response to hypoxia observed during 
plethysmography experiments in the AMPK global knockout mice, FURA-2 calcium 
imaging techniques (Wyatt & Buckler, 2004; Wyatt et.al., 2007; Burlon et.al., 2009) 
were used to assess the functional integrity of the isolated carotid body type I cells. 
Isolated type I cells from WT mice were shown to depolarize in response to hypercapnia 
and/or hypoxia which led to entry of voltage-gated calcium (Buckler & Vaughan-Jones, 
1993, 1994a,b) and neurotransmitter release.  
Type I cells from the global AMPK α1 KO mice exhibited a robust response to 
hypercapnia but showed a mixed response to hypoxia.  Figure 32A, illustrates the 
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hypoxic response of a type I cell from an AMPK α1 KO mouse. A strong response to 
hypercapnia was observed in addition to a small hypoxic response, whereas in Figure 
32B, another AMPK α1 KO type I cell also showed a response to hypercapnia but little 
to no response to hypoxia.  Thus, it appears as if there is a mixed hypoxic response from 
the type I cells of the AMPK α1 KO mice.  The variable Ca2+ imaging response from the 
α1 KO mice seems to coincide with the variable response also seen in the 
plethysmography data where the percent change in frequency response to hypoxia was 
significantly less than the wildtype but, percent change in tidal volume increased and 
percent change in minute ventilation to hypoxia decreased but not significantly. In order 
to gain a better understanding of the aforementioned mixed hypoxic response, an increase 
in cell numbers is required for the global AMPK α1 KO imaging experiments. 
Calcium imaging data collected from type I cells of global AMPK α2 KO mice 
showed a strong response to hypercapnia (Figure 33B).  The hypoxic response was 
significantly smaller in the AMPK α2 KO compared to the control type I cells.  This 
decrease in hypoxic response is illustrated in Figure 33C by the significantly (p<0.03) 
lower ratiometric signal in the AMPK α2 KO type I cells compared to the WT cells. The 
significant attenuation of the hypoxic response in the global AMPK α2 KO type I cells 
confirms that the expression of the AMPK α2 subunit is necessary for a complete acute 
HVR and a complete response of the carotid body type I cells to hypoxia.  The lack of 
response to a hypoxic stimulus in the global AMPK α2 KO mice carotid body type I cells 
appears to support the reduced HVR observed in the AMPK α2 KO mice observed 
during the plethysmography experiments. The data show not only a reduced hypoxic 
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ventilatory response at the whole animal level but also a reduced response at the cellular 
level. 
 The mixed response of the AMPK α1 KO mice shown in the Ca2+ imaging data 
could be the result of AMPK α2 subunits compensating for the KO of α1 in some of the 
type I cells.  The expression level of each subunit varies among cells (Li et.al., 2006), 
thus one subunit may be expressed in higher amounts versus the other allowing it to 
compensate for knockout of the other subunit.  The AMPK α1 subunits may not be able 
to compensate for the loss of the AMPK α2 subunits, which may explain the lack of 
hypoxic response in the AMPK α2 KO mice.  Since the animals are global AMPK 
knockout mice and AMPK is knocked out throughout the entire organism central effects 
may be greater in the AMPK α2 KO versus the AMPK α1 KO mice due to tissue specific 
subunit expression differences.  Currently this is speculation and increasing (n) numbers 
are required to help strengthen this argument. Further data collection will hopefully result 
in a more consistent response to allow for a more solid explanation. 
 There appears to be almost a complete total ablation of the hypoxic response in 
AMPK α2 KO mice but not in AMPK α1 KO mice. Both the AMPK α1 and AMPK α2 
subunits appear to phosphorylate similar targets. It is therefore unlikely that AMPK α1 
and AMPK α2 have different targets in the type I cells so this cannot explain the 
observed differences with the knockout.  However, the expression levels of each subunit 
may vary in the carotid body therefore giving different results.  Expression of one subunit 
may be at a higher level and when it is knocked out this may have a larger effect on 
signal transduction than knocking out a subunit with lower expression levels.  
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  Also, it is not known what the tissue specific subunit combinations are, so 
different isoforms of AMPK maybe expressed at different levels in the different KO 
mice. The various subunit combinations may target AMPK expression to different 
locations such that the AMPK α2 subunits may be targeted to the plasma membrane 
whereas the α1 is localized elsewhere. It has been reported in a variety of cell lines and 
skeletal muscle tissue (Salt et.al.,1998; McGee et.al., 2003) that a significantly greater 
portion of AMPK α2 is localized in the nucleus versus that of the α1 subunit. Therefore, 
knocking out one or the other subunit may result in a different response based upon 
subunit location and expression level. This may help to explain why there is complete 
knockout of the hypoxic response in the AMPK α2 global KO mice but a mixed response 
reported in the α1 KO mice.  In order to quantify alpha subunit expression levels, a 
Western Blot would be an ideal tool, however, due to the small size of the carotid body 
very little tissue is available so a Western Blot would not be possible.  The only 
alternative possible method is to use single-cell RT-PCR to examine the protein level 
expression of AMPK α1 and AMPK α2 subunits to determine if one subunit is being 
expressed at a higher level.   
 
 
AMPK and Multiple Targets 
One challenge in carotid body research is the interspecies heterogeneity of 
oxygen-sensitive ion channels.  Many of the channels expressed in the carotid body are 
not oxygen sensitive in other tissues.  The absence of oxygen sensing capabilities is due 
to a lack of the necessary pathway to sense changes in oxygen levels and inhibit the 
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potassium channel. Recent research has shown that AMPK has multiple ion channel 
targets (Dallas et.al., 2009; Evans et.al., 2009; Kréneisz et.al., 2009).  Expression of 
oxygen-sensitive potassium channels inhibited via activation of AMPK is species 
dependent and expression of these channels is also different among animals. For example 
it has been reported that mice have the following oxygen-sensitive K+ channels: Kv2.1 
(Ikematsu et.al., 2011), Kv3 (Pérez-García et.al., 2004), and possibly TASK-1 (Trapp 
et.al., 2008); whereas rats are shown to have BKCa (Peers, 1990; Wyatt & Peers, 1995), 
TASK1/3 (Buckler, 1997; Buckler et.al., 2000; Kim et.al., 2009) and possibly TREK 
(Kréneisz et.al., 2009) channels.  AMPK activation leads to phosphorylation of a target 
protein(s) and the aforementioned potassium channels have proteins that contain AMPK 
phosphorylation sites, thus more than one potassium channel maybe inhibited when 
AMPK is activated.  As a result, it is possible to have multiple oxygen-sensitive channels 
in an animal.  Knocking out or altering one of the channels may still result in retention of 
a hypoxic response because another AMPK targeted channel may be able to compensate 
for the loss (Oretega-Sáenz, et.al., 2010). Thus, it appears there is evidence in favor of 
AMPK being promiscuous because it is able to interact with multiple ion channel targets 




In addition to AMPK it has been suggested over the last year or two that hydrogen 
sulfphide, a naturally occurring ‘gasotransmitter’, plays a role in carotid body oxygen 
sensing through redox modulation in type I cells (Li et.al., 2010; Peng et.al., 2010).  
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Hydrogen sulfide is produced endogenously in cells via the breakdown of cysteine and 
homocysteine by the enzymes cystathionine-β-synthase (CBS) and cystathionine-γ-lyase 
(CSE) (Mustafa et.al., 2009; Gadalla & Snyder, 2010).  Cystathionine-β-synthase is the 
main H2S producing enzyme found in the brain whereas, cystathionine-γ-lyase is found in 
the glomus cells of the carotid body (Peng et.al., 2010; Li et.al., 2010 ). Hypoxia 
increases the production of H2S in the carotid body (Peng et.al., 2010) via a stimulus 
dependent manner. The mechanism as to how H2S actually stimulates the carotid body is 
not exactly known but it has been shown that excitation of chemoreceptors through 
exogenous H2S can be blocked by removing external calcium (Li et.al., 2010; Peng et.al., 
2010).  Inhibition of BKCa channels (Li et.al., 2010) by H2S has been reported but this 
alone is not likely to excite the type I cells because these potassium channels are not 
active under resting conditions (Buckler, 1997).   
H2S has been reported to excite carotid body type I cells through inhibition of a 
background (TASK) potassium current leading to cell depolarization and voltage-gated 
entry, which mirrors the response to hypoxia (Buckler, 2012). Concerns have arisen in 
regards to the concentrations of exogenous H2S required to excite the chemoreceptors and 
if these levels mirror those found in vivo (Haouzi et.al., 2011).  Hydrogen sulfide is 
highly membrane permeable and in order to generate a [Ca2+]i response levels of H2S 
need to be greater than 2.5 µM and in some cases greater than 7.5 µM (Mathai et.al., 
2009).  The extreme levels required to generate even a small response pose a problem for 
H2S to be seen as an oxygen sensor because type I cells are not capable of producing H2S 
at this level (Buckler, 2012).   
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 H2S is also a known cytochrome oxidase inhibitor (Erecinska & Wilson, 1981) 
and has been shown to inhibit mitochondrial function via NADH autofluorescene at 
concentrations of 2.5 µM (H2S) and above (Buckler, 2012).  It does not appear as if H2S 
plays any significant role outside of inhibition of oxidative phosphorylation, as it does not 
have any further effect on channel activity in the presence of cyanide (Buckler, 2012).  In 
addition, the extreme levels of hydrogen sulfide required to excite carotid body type I 
cells does not make H2S a likely candidate for mediating hypoxia in isolated type I cells 
as they are not capable of generating such large amounts of H2S.  
This dissertation suggests that AMPK does indeed couple hypoxic inhibition of 
oxidative phosphorylation of type I cells and plays a key role in the acute hypoxic 
ventilatory response.  The data show that AMPK α subunits are necessary for a complete 
hypoxic ventilatory response as well as carotid body type I cells response to hypoxia.  
This work is supported by preliminary data from collaborators, in which knock out of 
LKB1, an upstream kinase of AMPK (Figure 5), in type I cells also gives an attenuated 
hypoxic ventilatory response in mice (Evans, 2012).  Thus, not only does knockout of 
AMPK α catalytic subunits affect the hypoxic response, but also knocking out an 
upstream kinase which activates AMPK results in an attenuated HVR.  These data 
suggest that the LKB1-AMPK signaling pathway is required for a hypoxic response 




Summary of Findings 
•  During exposure to 8% oxygen, both AMPK α1 and AMPK α2 knockout mice 
have a significant decrease in percent change in frequency of breathing 
•  AMPK α2 knockout mice also show a significant attenuation in percent change in 
minute ventilation during exposure to 8% oxygen 
•  The plethysmography data show the AMPK α subunits maybe involved in 
baseline breathing and generation of an acute hypoxic response 
•  Calcium imaging data show a decrease in the hypoxic response may be due to an 
effect at the level of the carotid body 
•  Knocking out AMPK globally could have central effects, thus TH-targeted 
knockout mice could be useful genetic tools to minimize possible central effects 










One methodological approach that might get around the problem of non-selective 
targeting of AMPK knockout is to block or knockdown its expression through RNA 
interference.  RNA interference is a process where double stranded DNA (dsDNA) is 
able to regulate gene expression. Small interfering RNA (siRNA) is a double stranded 
RNA molecule that is 21 nucleotides in length and is complementary to an mRNA 
transcript (Fire et.al., 1998).  When siRNA is introduced into a cell one strand is 
processed into the RNA-induced silencing complex (RISC) where it binds the 
complementary mRNA (Hammond et.al., 2000).  The nuclease activity of RISC results in 
the complimentary mRNA being degraded by a member of the Argonaute (AGO) family 
(Hammond et.al., 2001), which no longer allows for protein translation (Scherr et.al., 
2003; Doi et.al., 2003).  SiRNA is not useful for long-term studies as it is diluted upon 
cell division (Rao et.al., 2009).   
 An alternative method is to use short hairpin RNAs (shRNAs) to knockdown a 
specific target protein.  shRNA is a sequence of RNA containing a tight hairpin structure 
which is used to silence gene expression through RNAi (Bernstein et.al., 2001).  shRNA 
is transcribed from a DNA template and uses a vector introduced into cells via the U6 
promoter ensuring shRNA is always expressed (Harborth et.al., 2003; Elbashir et.al., 
2001).  The vector allows for heritable gene silencing as it is passed onto daughter cells.   
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Generation of a novel shRNA, which simultaneously targets both the AMPK α1 and 
AMPK α2 subunits, has been developed in collaboration with Dr. Tom Brown’s lab, 
Wright State University.  Tissue-specific knockdown of AMPK α1 and AMPK α2 was 
accomplished through an shRNA construct (Figure 35).  The construct is under a U6 
promoter that is disrupted by a loxP cassette.  The loxP cassette contains a stop sequence 
that is flanked on either side by a loxP site.  When the promoter contains this cassette it 
becomes non-functional and the shRNA is not expressed and knockdown of AMPK does 
not occur.  A tyrosine hydroxylase tissue specific promoter was used to direct the 
expression of Cre recombinase with a Myc tag (pLv-MCS-THp-CreMyc).  The use of 
Cre, along with the shRNA that has a disrupted promoter will restore the promoter so 
shRNA is made in only cells that express TH, which includes the carotid body. The final 
construct has been generated and is currently being put into lentivirus.  Lentivirus will 
infect 2-8 cell mice/rat embryos to ensure a full body incorporation of lentiviral DNA.  
All cells within the embryo will contain the viral DNA and only those cells expressing 
TH will make the shRNA and have knockdown of AMPKα1 and AMPK α2.  Once 
infected the embryos will be transplanted into a pseudopregnant mother.  Tissue specific 
knockdown of both AMPKα1 and AMPK α2 should occur in the embryos only in TH 
positive tissue and should not result in lethality since it is knockdown and not total 
knockout of both AMPK subunits.  These animals will then be used by the Wyatt lab to 
examine the whole animal hypoxic response via plethysmography as well as look at the 




Figure 35.   shRNA Construct.  (A.) shRNA structure under control of a U6 promoter.  
(B.) shRNA structure with disrupted U6 promoter.  (C).  DNA Recombination catalyzed 
by cre recombinase at loxP sites located between U and Stop sequence and between the 
Stop sequence and 6P.  The Stop sequence is removed following binding of cre 
recombinase at the loxP sites with construct illustrated in (B.).  (D).  Virus structure.  
U6P: promoter; shRNA: short hairpin RNA; Stop: stop sequence; LoxP: loxP sites; 
U/6P: disrupted promoter; ThP: tyrosine hydroxylase promoter; Cre: cre recombinase; 
Myc tag: (pLv-MCS-THp-CreMyc) TH tissue specific promoter to direct expression of 
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Another alternative approach to targeting knockout of AMPK besides the TH-
targeted knockout mice would be to use dopamine transporter (DAT) (Augood et.al., 
1993) cre mice to specifically target knockout of AMPK to dopaminergic neurons in cre  
 recombinase expressing mice.  In order to direct expression of cre recombinase to 
dopaminergic neurons, cre is inserted downstream of the endogenous promoter DAT 
(DAT-cre) (Zhuang, et.al., 2005).  DAT-cre mice would also allow for AMPK α2 
subunits to be deleted in the carotid body type I cells but again be spared in most of the 
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ADP: adenosine diphosphate 
AGO: Argonaute 
AICAR: 5-aminoimidazole-4-carboxamide ribose α: alpha  
AMP: adenosine monophosphate 
AMPK: amp activated protein kinase 
AMP-PCP: β ,γ-methyleniadenosine 5'-triphosphate ATP: adenosine-5-triphosphate 
ASC: association with SNF1 kinase 
ATP-γ: adenosine-5'-O-(3-thiotriphosphate) 
β: beta  
BKCa: maxi K+ potassium channel 
° C: degrees centigrade 
Ca2+: calcium 
[Ca2+]i: intracellular calcium  
CamKKβ: cam kinase kinase beta 
CB: carotid body 
CO: carbon monoxide 
CO2: carbon dioxide 
commNTS: commissural nucleus tractus solitarius 
cNTS: caudal nucleus tractus solitarius 
CSN: carotid sinus nerve 




DAT: dopamine transporter 
DNA: deoxyribonucleic acid 
dsDNA: double stranded deoxyribonucleic acid 
F: frequency 
FCCP: p-trifluorometoxyphenyl hydrazone 
Fl: flox 
γ: gamma 
GBD: glycogen binding domain 
g: gram 




Hif-1: hypoxia inducible factor 1 
HO-2: heme oxygenase-2 
H2S: hydrogen sulfphide 
HVD: hypoxic ventilatory decline 
HVR: hypoxic ventilatory response 
K+: potassium 
kDa: kilodalton 
KIS: kinase interaction sequence 
KO: knockout 
Kv: voltage-gated potassium channel 
LKB1: liver kinase B1 





MO25α: mouse protein 25-α 






NADH: nicotinamide adenine dinucleotide 
NADPH: nicotinamide adenine dinucleotide phosphate 
NE: norepinephrine 
NO: nitric oxide 
NT: neurotransmitter 
NTS: nucleus tractus solitarius 
O2: oxygen 
PAC: peripheral arterial chemoreceptor 
PCR: polymerase chain reaction 
PO2: partial pressure of oxygen 
PCO2: partial pressure of carbon dioxide 
pHi: intracellular pH 
pHo: extracellular pH 
P.S.I.: pounds per square inch 
R: respiratory ratio 
RISC: ribonucleic acid induced silencing complex 
RR: respiration rate 
RTN: retrotrapezoid nucleus 
RT-PCR: reverse transcriptase polymerase chain reaction 
shRNA: short hairpin ribonucleic acid 
SIDS: sudden infant death syndrome 
siRNA: small interfering ribonucleic acid 
STPD: standard temperature and pressure under dry conditions 
STRADα: ste 20-related adaptor protein-α 
Sub P: substance P 
TASK: acid (or alkali) sensitive K+-channels of the tandem P-domain K+-channel 
family 
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TH: tyrosine hydroxylase 
Thr-172: threonine 172 
UTP: uridine triphosphate 
V
.
  CO2: carbon dioxide excretion  
VE: minute ventilation 
VE/g: minute ventilation/gram 
V
.
  O2: oxygen consumption  
VT: tidal volume 
WT: wildtype 
ZMP: 5-aminoimidazole-4-carboxamide ribose monophosphate 
 
 
 
 
 
 
 
 
 
 
